[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 393
1. Aleagha ME, Montaseri A, Tahmasian M, Shobiri E, Torbaghan SS: Recurrent intracranial haemangiopericytoma compatible to synovial sarcoma. J Pak Med Assoc; 2010 Jul;60(7):586-8
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent intracranial haemangiopericytoma compatible to synovial sarcoma.
  • A rare case of intracranial haemangiopericytoma with a thrice recurrence, treated by gross total removal and local irradiation is presented.
  • [MeSH-major] Brain Neoplasms / surgery. Hemangiopericytoma / surgery
  • [MeSH-minor] Adult. Humans. Immunohistochemistry. Male. Neoplasm Recurrence, Local. Radiotherapy, Adjuvant. Sarcoma, Synovial / diagnosis

  • Genetic Alliance. consumer health - Synovial sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20578615.001).
  • [ISSN] 0030-9982
  • [Journal-full-title] JPMA. The Journal of the Pakistan Medical Association
  • [ISO-abbreviation] J Pak Med Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


2. Chamberlain MC, Johnston SK: Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma. Cancer; 2009 Oct 15;115(20):4775-82
Hazardous Substances Data Bank. DACARBAZINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma.
  • Time to tumor progression ranged from 1 to 7 months (median, 2 months).
  • CONCLUSIONS: TMZ in this dose schedule demonstrated little efficacy in a cohort of adults with recurrent, intracranial, platinum-refractory ependymoma.
  • [MeSH-major] Antineoplastic Agents, Alkylating / therapeutic use. Dacarbazine / analogs & derivatives. Ependymoma / drug therapy. Supratentorial Neoplasms / drug therapy
  • [MeSH-minor] Adult. Carboplatin / therapeutic use. Cisplatin / therapeutic use. Disease-Free Survival. Drug Resistance, Neoplasm. Female. Ferrous Compounds. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Retreatment

  • Genetic Alliance. consumer health - Ependymoma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. CARBOPLATIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009 American Cancer Society.
  • (PMID = 19569246.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; 0 / Ferrous Compounds; 33269-57-7 / EX 10-478; 7GR28W0FJI / Dacarbazine; 85622-93-1 / temozolomide; BG3F62OND5 / Carboplatin; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


3. Idowu OE, Apemiye RA: Delay in presentation and diagnosis of adult primary intracranial neoplasms in a tropical teaching hospital: a pilot study. Int J Surg; 2009 Aug;7(4):396-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Delay in presentation and diagnosis of adult primary intracranial neoplasms in a tropical teaching hospital: a pilot study.
  • Sixty-three adult patients with intracranial neoplasms were studied prospectively over a 2 year period.
  • [MeSH-major] Brain Neoplasms / diagnosis. Brain Neoplasms / mortality. Cause of Death. Health Services Accessibility. Neoplasm Invasiveness / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Biopsy, Needle. Developing Countries. Early Detection of Cancer. Female. Hospitals, Teaching. Humans. Immunohistochemistry. Male. Middle Aged. Needs Assessment. Neoplasm Staging. Nigeria. Pilot Projects. Prospective Studies. Risk Assessment. Survival Analysis. Time Factors. Tropical Climate. Young Adult

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Int J Surg. 2009 Oct;7(5):485 [19635600.001]
  • (PMID = 19595802.001).
  • [ISSN] 1743-9159
  • [Journal-full-title] International journal of surgery (London, England)
  • [ISO-abbreviation] Int J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


Advertisement
4. Lynch JC, Ferreira LA, Welling L, Schulz RC: Multiple intracranial meningiomas: diagnosis, biological behavior and treatment. Arq Neuropsiquiatr; 2008 Sep;66(3B):702-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multiple intracranial meningiomas: diagnosis, biological behavior and treatment.
  • Multiple intracranial meningiomas (MIM) are a rare pathology when not associated with neurofibromatosis.
  • The prevalence rate of those tumors varied from 2.3 to 8.9% of all intracranial meningiomas.
  • OBJECTIVE: To present, analyze and discuss the cases of seven patients diagnosed with multiple intracranial meningiomas, describing their clinical and histological characteristics, as well as their biological behavior.
  • [MeSH-major] Meningeal Neoplasms / diagnosis. Meningioma / diagnosis. Neoplasms, Multiple Primary / diagnosis
  • [MeSH-minor] Adult. Aged, 80 and over. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Staging. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18949266.001).
  • [ISSN] 1678-4227
  • [Journal-full-title] Arquivos de neuro-psiquiatria
  • [ISO-abbreviation] Arq Neuropsiquiatr
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


5. Saito R, Kumabe T, Watanabe M, Jokura H, Shibuya M, Nakazato Y, Tominaga T: Low-grade fibromyxoid sarcoma of intracranial origin. J Neurosurg; 2008 Apr;108(4):798-802
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low-grade fibromyxoid sarcoma of intracranial origin.
  • The low-grade fibromyxoid sarcoma is a rare sarcoma of the deep soft tissue that is characterized as an indolent but metastasizing soft-tissue neoplasm with a deceptively benign histological appearance.
  • Only one case of intracranial origin has been previously reported in the literature.
  • A high rate of local recurrence and eventual metastasis has been demonstrated for this tumor in deep soft tissue.
  • The tumor is still under control without any evidence of extracranial metastasis.
  • [MeSH-major] Brain Neoplasms / diagnosis. Brain Neoplasms / therapy. Sarcoma / diagnosis. Sarcoma / therapy
  • [MeSH-minor] Adult. Combined Modality Therapy. Humans. Magnetic Resonance Imaging. Male. Neoplasm Recurrence, Local / prevention & control. Radiosurgery. Radiotherapy, Adjuvant. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18377261.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


6. de Tella OI Jr, Silva LR, Stavale JN, Herculano MA, de Paiva Neto MA, Agner C: Aggressive intracranial fibromatosis: case report. Arq Neuropsiquiatr; 2006 Jun;64(2B):516-9
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aggressive intracranial fibromatosis: case report.
  • Intracranial fibromatosis is extremely rare and requires aggressive treatment to prevent recurrence.
  • A combined anterior craniofacial approach was performed; complete resection with surgical margin was impossible due to the localization of the tumor and relation to important neurovascular structures.
  • [MeSH-major] Brain Neoplasms / diagnosis. Fibromatosis, Aggressive / diagnosis
  • [MeSH-minor] Adult. Craniotomy / methods. Female. Humans. Magnetic Resonance Imaging. Neoplasm Recurrence, Local / surgery. Reoperation. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Aggressive Fibromatosis.
  • Genetic Alliance. consumer health - Fibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16917630.001).
  • [ISSN] 0004-282X
  • [Journal-full-title] Arquivos de neuro-psiquiatria
  • [ISO-abbreviation] Arq Neuropsiquiatr
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


7. Figarella-Branger D, Metellus P, Barrié M, Maues de Paula A, Fernandez C, Polivka M, Vital A, Labrousse F, Vignaud JM, Laquerrière A, Rousselet MC, Lacroix C, Saikali S, Chapon F, Gontier MF, Chrétien F, Babin P, Rigau V, Vandenbos F, Peoc'h M, Kujas M, Chinot O, Gouvernet J, Giorgi R, Guyotat J, Jouvet A: [Intracranial ependymomas in adult patients. Diagnosis and histological prognostic factors]. Neurochirurgie; 2007 Jun;53(2-3 Pt 1):76-84
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intracranial ependymomas in adult patients. Diagnosis and histological prognostic factors].
  • BACKGROUND: Intracranial ependymomas are rare in adults and histopathological prognostic factors are poorly determined.
  • MATERIAL: Between 1990 and 2004, 216 adult patients with newly diagnosed ependymomas were treated in 19 French centers.
  • [MeSH-major] Brain Neoplasms / mortality. Brain Neoplasms / pathology. Ependymoma / mortality. Ependymoma / pathology
  • [MeSH-minor] Adult. Disease Progression. Female. Humans. Male. Neoplasm Staging. Neurosurgical Procedures. Prognosis. Retrospective Studies. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17445840.001).
  • [ISSN] 0028-3770
  • [Journal-full-title] Neuro-Chirurgie
  • [ISO-abbreviation] Neurochirurgie
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] France
  •  go-up   go-down


8. Andrade FG, de Aguiar PH, Matushita H, Taricco MA, Oba-Shinjo SM, Marie SK, Teixeira MJ: Intracranial and spinal ependymoma: series at Faculdade de Medicina, Universidade de São Paulo. Arq Neuropsiquiatr; 2009 Sep;67(3A):626-32
MedlinePlus Health Information. consumer health - Childhood Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial and spinal ependymoma: series at Faculdade de Medicina, Universidade de São Paulo.
  • OBJECTIVE: Ependymomas are rare intracranial neuroepithelial tumors and the most common location is intramedullary.
  • METHOD: Data of clinical presentation, tumor location, duration of symptoms, degree of resection and complementary treatment of 34 patients with intracranial ependymoma and 31 with intramedullary ependymoma who underwent surgery in the last ten years were collected and correlated with the recurrence time and overall survival.
  • RESULTS: There was statistically significant correlation between the degree of resection and intracranial tumor location, although it is not a hallmark of recurrence.
  • CONCLUSION: The location of the intracranial tumor is connected with the degree of resection; however it is not a predictive factor to overall survival.
  • [MeSH-major] Brain Neoplasms / surgery. Ependymoma / surgery. Spinal Cord Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Disease-Free Survival. Female. Hospitals, University. Humans. Infant. Male. Middle Aged. Neoplasm Recurrence, Local. Young Adult

  • Genetic Alliance. consumer health - Ependymoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19722039.001).
  • [ISSN] 1678-4227
  • [Journal-full-title] Arquivos de neuro-psiquiatria
  • [ISO-abbreviation] Arq Neuropsiquiatr
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


9. Johnson N, Sermer M, Lausman A, Maxwell C: Obstetric outcomes of women with intracranial neoplasms. Int J Gynaecol Obstet; 2009 Apr;105(1):56-9
MedlinePlus Health Information. consumer health - Tumors and Pregnancy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Obstetric outcomes of women with intracranial neoplasms.
  • OBJECTIVE: To determine the obstetric outcomes of women diagnosed with a primary intracranial neoplasm prior to or during pregnancy and the puerperium.
  • Thirteen patients were diagnosed prior to pregnancy (group 1); tumor growth or recurrence during pregnancy occurred in 3 patients.
  • [MeSH-major] Brain Neoplasms / complications. Pregnancy Complications, Neoplastic / physiopathology. Pregnancy Outcome
  • [MeSH-minor] Adult. Cesarean Section / statistics & numerical data. Databases, Factual. Female. Glioma / complications. Glioma / physiopathology. Glioma / surgery. Humans. Infant, Newborn. Intensive Care Units, Neonatal / statistics & numerical data. Meningioma / complications. Meningioma / physiopathology. Meningioma / surgery. Neoplasm Recurrence, Local / epidemiology. Ontario / epidemiology. Postpartum Period. Pregnancy. Premature Birth / etiology. Retrospective Studies. Vision Disorders / epidemiology. Vision Disorders / etiology

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19155008.001).
  • [ISSN] 1879-3479
  • [Journal-full-title] International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
  • [ISO-abbreviation] Int J Gynaecol Obstet
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


10. Metellus P, Barrie M, Figarella-Branger D, Chinot O, Giorgi R, Jouvet A, Guyotat J: [Intracranial ependymomas in adult patients. Retrospective analysis of 121 cases from the multicentric French study]. Neurochirurgie; 2007 Jun;53(2-3 Pt 1):66-75
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intracranial ependymomas in adult patients. Retrospective analysis of 121 cases from the multicentric French study].
  • Ependymomas are rare intracranial tumors observed in adults.
  • We report a retrospective study of 121 cases intracranial ependymomas diagnosed between 1990 and 2004 in adult patients.
  • This study demonstrated that extent of surgery and tumor grade are the two main prognostic factors in adult intracranial ependymomas with respect to overall and progression-free survival.
  • [MeSH-major] Brain Neoplasms / pathology. Ependymoma / pathology. Neurosurgical Procedures / methods
  • [MeSH-minor] Disease-Free Survival. Female. Follow-Up Studies. France / epidemiology. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Staging. Neoplasm, Residual / epidemiology. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17475290.001).
  • [ISSN] 0028-3770
  • [Journal-full-title] Neuro-Chirurgie
  • [ISO-abbreviation] Neurochirurgie
  • [Language] fre
  • [Publication-type] Clinical Trial; English Abstract; Journal Article; Multicenter Study
  • [Publication-country] France
  •  go-up   go-down


11. Kim SD, Park JY, Choi WS, Kim SH, Lim DJ, Chung HS: Intracranial recurrence of the scalp dermatofibrosarcoma. Clin Neurol Neurosurg; 2007 Feb;109(2):172-5
Hazardous Substances Data Bank. IMATINIB MESYLATE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial recurrence of the scalp dermatofibrosarcoma.
  • Despite surgical intervention and radiotherapy, a recurrent tumor associated with infiltration to the calvarium was detected.
  • Two years later, however, the patient was readmitted to our institution as a result of tumor recurrence with intracranial involvement.
  • Scalp dermatofibrosarcoma is an uncommon but aggressive scalp tumor; therefore, wide local excision with good margins is essential to decrease the risk of regional recurrence.
  • Close surveillance in these cases is necessary due to late tumor recurrences.
  • [MeSH-major] Cranial Sinuses / surgery. Dermatofibrosarcoma / surgery. Neoplasm Recurrence, Local / surgery. Scalp / surgery. Skin Neoplasms / surgery. Skull Neoplasms / secondary
  • [MeSH-minor] Adult. Benzamides. Chemotherapy, Adjuvant. Combined Modality Therapy. Embolization, Therapeutic. Female. Humans. Imatinib Mesylate. Magnetic Resonance Imaging. Neoadjuvant Therapy. Neoplasm Invasiveness. Piperazines / therapeutic use. Pyrimidines / therapeutic use. Reoperation

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16757109.001).
  • [ISSN] 0303-8467
  • [Journal-full-title] Clinical neurology and neurosurgery
  • [ISO-abbreviation] Clin Neurol Neurosurg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Benzamides; 0 / Piperazines; 0 / Pyrimidines; 8A1O1M485B / Imatinib Mesylate
  •  go-up   go-down


12. Plans G, Brell M, Cabiol J, Villà S, Torres A, Acebes JJ: Intracranial retrograde dissemination in filum terminale myxopapillary ependymomas. Acta Neurochir (Wien); 2006 Mar;148(3):343-6; discussion 346
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial retrograde dissemination in filum terminale myxopapillary ependymomas.
  • We describe the case of a 23-year-old man diagnosed with intracranial subarachnoid dissemination of a filum terminale ME three years after the initial diagnosis.
  • [MeSH-major] Brain Neoplasms / secondary. Cauda Equina / pathology. Ependymoma / secondary. Meningeal Neoplasms / secondary. Neoplasm Metastasis / physiopathology. Spinal Cord Neoplasms / pathology. Subarachnoid Space / physiopathology
  • [MeSH-minor] Adult. Decompression, Surgical. Disease Progression. Headache / diagnosis. Headache / etiology. Headache / physiopathology. Humans. Hypothalamic Neoplasms / radiotherapy. Hypothalamic Neoplasms / secondary. Hypothalamus / pathology. Hypothalamus / physiopathology. Hypothalamus / surgery. Laminectomy. Low Back Pain / etiology. Low Back Pain / physiopathology. Low Back Pain / surgery. Lumbar Vertebrae / surgery. Magnetic Resonance Imaging. Male. Pituitary Gland, Posterior / pathology. Pituitary Gland, Posterior / physiopathology. Pituitary Gland, Posterior / surgery. Radiotherapy / methods. Third Ventricle / pathology. Third Ventricle / physiopathology. Third Ventricle / surgery. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16362177.001).
  • [ISSN] 0001-6268
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Austria
  • [Number-of-references] 35
  •  go-up   go-down


13. Kawabata Y, Takahashi JA, Arakawa Y, Hashimoto N: Long-term outcome in patients harboring intracranial ependymoma. J Neurosurg; 2005 Jul;103(1):31-7
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term outcome in patients harboring intracranial ependymoma.
  • OBJECT: The prognostic significance of tumor grade and resection and the efficacy of prophylactic radiation remain controversial in the management of intracranial ependymoma.
  • The outcomes in patients with intracranial ependymoma treated at the Kyoto University Hospital were reviewed retrospectively, and prognostic significance was analyzed.
  • Overall survival and progression-free survival rates were significantly higher in patients with Grade II ependymoma (p = 0.006 and 0.004, respectively) and in patients who had undergone gross-total resection of the tumor (p = 0.002 and 0.04, respectively).
  • In nine patients the ependymoma recurred only at the original tumor site.
  • All relapses of the Grade II ependymoma initially occurred at the primary tumor site.
  • Histological grade and extent of resection were significantly associated with tumor dissemination (p = 0.0034 and 0.0011, respectively).
  • CONCLUSIONS: Tumor grade and resection are the two important prognostic factors with respect to patient survival, tumor recurrence, and tumor dissemination.
  • [MeSH-major] Brain Neoplasms / mortality. Brain Neoplasms / therapy. Ependymoma / mortality. Ependymoma / therapy. Neoplasm Recurrence, Local / mortality
  • [MeSH-minor] Adolescent. Adult. Aged. Antineoplastic Agents / therapeutic use. Chemotherapy, Adjuvant. Child. Child, Preschool. Female. Follow-Up Studies. Humans. Infant. Male. Middle Aged. Radiotherapy, Adjuvant. Retrospective Studies. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Ependymoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Neurosurg. 2006 Sep;105(3):503; author reply 503-4 [16961153.001]
  • [CommentIn] J Neurosurg. 2005 Jul;103(1):4; discussion 4-5 [16121965.001]
  • (PMID = 16121970.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


14. Chamberlain MC, Glantz MJ: Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma. Neurosurgery; 2008 Oct;63(4):720-6; author reply 726-7
Hazardous Substances Data Bank. VINCRISTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
  • OBJECTIVE: Hemangiopericytoma (HPC) is an uncommon primary brain tumor with an almost invariable tendency to recur and metastasize.
  • We undertook a retrospectively collected case series of recurrent intracranial HPCs treated with salvage chemotherapy with the primary objective of evaluating progression-free survival.
  • Eight patients developed disseminated disease, all with multifocal intracranial disease (5 with cerebrospinal fluid dissemination, 4 with extraneural metastases).
  • CONCLUSION: Salvage chemotherapy demonstrated modest efficacy with acceptable toxicity in this cohort of adult patients with recurrent surgery- and radiotherapy-refractory intracranial HPC.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Brain Neoplasms / drug therapy. Hemangiopericytoma / drug therapy. Neoplasm Recurrence, Local / drug therapy. Salvage Therapy / methods
  • [MeSH-minor] Adult. Cisplatin / adverse effects. Cisplatin / therapeutic use. Cyclophosphamide / adverse effects. Cyclophosphamide / therapeutic use. Cytarabine / administration & dosage. Disease Progression. Disease-Free Survival. Doxorubicin / adverse effects. Doxorubicin / therapeutic use. Drug Administration Routes. Drug Administration Schedule. Etoposide / adverse effects. Etoposide / therapeutic use. Female. Humans. Ifosfamide / adverse effects. Ifosfamide / therapeutic use. Interferon-alpha / administration & dosage. Kaplan-Meier Estimate. Liposomes. Magnetic Resonance Spectroscopy. Male. Middle Aged. Positron-Emission Tomography. Rare Diseases. Retrospective Studies. Survival Rate. Treatment Outcome. Vincristine / adverse effects. Vincristine / therapeutic use

  • Genetic Alliance. consumer health - Hemangiopericytoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • Hazardous Substances Data Bank. CYTARABINE .
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. ETOPOSIDE .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18981882.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Interferon-alpha; 0 / Liposomes; 04079A1RDZ / Cytarabine; 5J49Q6B70F / Vincristine; 6PLQ3CP4P3 / Etoposide; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; Q20Q21Q62J / Cisplatin; UM20QQM95Y / Ifosfamide; CAV protocol; ICE protocol 1
  •  go-up   go-down


15. Kano H, Niranjan A, Kondziolka D, Flickinger JC, Lunsford LD: Outcome predictors for intracranial ependymoma radiosurgery. Neurosurgery; 2009 Feb;64(2):279-87; discussion 287-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Outcome predictors for intracranial ependymoma radiosurgery.
  • OBJECTIVE: To develop outcome predictors after stereotactic radiosurgery (SRS) in patients with intracranial ependymomas who had received previous fractionated radiation therapy, we compared tumor control, survival, and complications with tumor grade, volume, age of patients, and imaging characteristics.
  • Lower histological tumor grade was not significantly associated with better progression-free survival (P = 0.725).
  • Factors associated with an improved progression-free survival included smaller tumor volume and homogeneous tumor contrast enhancement in low-grade ependymomas.
  • [MeSH-major] Brain Neoplasms / epidemiology. Brain Neoplasms / surgery. Ependymoma / epidemiology. Ependymoma / surgery. Neoplasm Recurrence, Local / epidemiology. Neoplasm Recurrence, Local / prevention & control. Outcome Assessment (Health Care) / methods. Radiosurgery / statistics & numerical data
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Female. Humans. Incidence. Male. Middle Aged. Pennsylvania / epidemiology. Retrospective Studies. Risk Assessment / methods. Risk Factors. Treatment Outcome. Young Adult

  • Genetic Alliance. consumer health - Ependymoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19190457.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


16. Guyotat J, Metellus P: [Intracranial ependymomas in adult patients. Prognostic factors, place of surgery and complementary treatment]. Neurochirurgie; 2007 Jun;53(2-3 Pt 1):85-94
MedlinePlus Health Information. consumer health - Complementary and Integrative Medicine.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intracranial ependymomas in adult patients. Prognostic factors, place of surgery and complementary treatment].
  • Prognostic factors and optimal therapy for adult intracranial ependymoma are still debated.
  • [MeSH-major] Brain Neoplasms / mortality. Brain Neoplasms / pathology. Complementary Therapies / methods. Ependymoma / mortality. Ependymoma / pathology. Neurosurgical Procedures / methods
  • [MeSH-minor] France / epidemiology. Humans. Neoplasm Recurrence, Local / epidemiology. Prognosis. Survival Rate

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17418281.001).
  • [ISSN] 0028-3770
  • [Journal-full-title] Neuro-Chirurgie
  • [ISO-abbreviation] Neurochirurgie
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Multicenter Study; Review
  • [Publication-country] France
  • [Number-of-references] 65
  •  go-up   go-down


17. Bolat F, Kayaselcuk F, Tarim E, Kilicdag E, Bal N: Congenital intracranial teratoma with massive macrocephaly and skull rupture. Fetal Diagn Ther; 2008;23(1):1-4
MedlinePlus Health Information. consumer health - Hydrocephalus.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Congenital intracranial teratoma with massive macrocephaly and skull rupture.
  • OBJECTIVE: Congenital intracranial tumors are rare and only account for 0.5-1.5% of all pediatric brain tumors.
  • Teratoma is the most frequently encountered intracranial tumor at birth.
  • Massive congenital intracranial teratoma is an extremely rare neoplasm with a poor prognosis.
  • Herein we report a massive intracranial teratoma causing skull rupture.
  • CASE REPORT: A fetus with a congenital intracranial teratoma presenting with a disproportionately enlarged head at 25 weeks of gestation is presented.
  • Prenatal ultrasonography demonstrated a huge, heterogeneous intracranial mass, and midline structures and ventricles could not be observed.
  • Autopsy was perforated, and histopathologic examination of the samples taken from the intracranial mass revealed an immature teratoma.
  • CONCLUSION: Although congenital intracranial teratomas are rare, they may reach enormous sizes.
  • Regular follow-up of the fetus may lead to early diagnosis of immature intracranial teratomas and prevent the mother from having further complications either due to intrauterine fetal death orpsychological trauma of giving birth to a heavily malformed baby.
  • [MeSH-major] Brain Neoplasms / pathology. Hydrocephalus / pathology. Skull / pathology. Teratoma / pathology
  • [MeSH-minor] Adult. Female. Fetal Death / etiology. Fetal Death / pathology. Fetal Diseases / pathology. Humans. Pregnancy. Prenatal Diagnosis / methods. Rupture / complications. Rupture / pathology

  • Genetic Alliance. consumer health - Macrocephaly.
  • Genetic Alliance. consumer health - Teratoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 S. Karger AG, Basel
  • (PMID = 17934288.001).
  • [ISSN] 1421-9964
  • [Journal-full-title] Fetal diagnosis and therapy
  • [ISO-abbreviation] Fetal. Diagn. Ther.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Switzerland
  • [Number-of-references] 19
  •  go-up   go-down


18. Marakovic J, Vilendecic M, Marinovic T, Lambasa S, Grahovac G: Intracranial recurrence and distant metastasis of scalp dermatofibrosarcoma protuberans. J Neurooncol; 2008 Jul;88(3):305-8
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial recurrence and distant metastasis of scalp dermatofibrosarcoma protuberans.
  • Only few cases of scalp dermatofibrosarcoma protuberans with intracranial and distant metastasis have been reported.
  • Here we report a case of scalp dermatofibrosarcoma protuberans with frequent local recurrence, intracranial invasion and with distant lung metastasis during 6 years of treatment.
  • Close surveillance of patients with scalp dermatofibrosarcoma is necessary due recurrence nature of tumor.
  • [MeSH-major] Dermatofibrosarcoma / secondary. Head and Neck Neoplasms / pathology. Lung Neoplasms / secondary. Neoplasm Recurrence, Local / pathology. Scalp / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Adult. Fatal Outcome. Humans. Magnetic Resonance Imaging. Male


19. Stenstam BH, Pellettieri L, Sorteberg W, Rezaei A, Sköld K: BNCT for recurrent intracranial meningeal tumours - case reports. Acta Neurol Scand; 2007 Apr;115(4):243-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] BNCT for recurrent intracranial meningeal tumours - case reports.
  • OBJECTIVES: The investigation was designed to explore the efficacy of boron neutron capture therapy (BNCT) as treatment for recurrent intracranial meningeal tumours.
  • RESULTS: The present results indicate that BNCT could be effective in prolonging time to recurrence, and thus in extending survival time, for patients with recurrent intracranial meningeal tumours.
  • CONCLUSIONS: BNCT is potentially an effective radiation treatment modality for malignant intracranial meningeal tumours, which could increase progression-free survival, thus reducing the need for additional surgical interventions.
  • [MeSH-major] Boron Neutron Capture Therapy. Brain Neoplasms / radiotherapy. Chondrosarcoma, Mesenchymal / radiotherapy. Meningeal Neoplasms / radiotherapy. Meningioma / radiotherapy. Neoplasm Recurrence, Local / radiotherapy
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17376121.001).
  • [ISSN] 0001-6314
  • [Journal-full-title] Acta neurologica Scandinavica
  • [ISO-abbreviation] Acta Neurol. Scand.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  •  go-up   go-down


20. Tun K, Ozen O, Kaptanoglu E, Gurcan O, Beskonakli E, Celasun B: Primary intracranial low-grade fibromyxoid sarcoma (Evans tumor). J Clin Neurosci; 2008 Nov;15(11):1298-301

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary intracranial low-grade fibromyxoid sarcoma (Evans tumor).
  • Low-grade fibromyxoid sarcoma was first described in 1987 as a rare soft tissue neoplasm characterized by a bland and deceptively benign histological appearance but with aggressive behavior.
  • A right frontal mass was detected on MRI and he was operated upon to remove the intracranial mass.
  • Although primary intracranial low-grade fibromyxoid sarcoma has characteristic histological features, clinical and radiological correlation is necessary to make the correct diagnosis.
  • [MeSH-major] Fibrosarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Humans. Magnetic Resonance Imaging. Male. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18771926.001).
  • [ISSN] 0967-5868
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


21. Almousa R, Nga ME, Sundar G: Marginal zone B-cell orbital lymphoma with intracranial involvement. Ophthal Plast Reconstr Surg; 2010 May-Jun;26(3):205-6
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Marginal zone B-cell orbital lymphoma with intracranial involvement.
  • Histopathology confirmed the diagnosis of orbital marginal zone B-cell lymphoma, which is an indolent type of lymphoma that can be associated with systemic lymphoma, but the intracranial association has not been previously described.
  • [MeSH-major] Brain Neoplasms / pathology. Lymphoma, B-Cell, Marginal Zone / pathology. Orbital Neoplasms / pathology
  • [MeSH-minor] Adult. Female. Humans. Neoplasm Invasiveness. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Orbital lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20489547.001).
  • [ISSN] 1537-2677
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Parsa AT, Wachhorst S, Lamborn KR, Prados MD, McDermott MW, Berger MS, Chang SM: Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. J Neurosurg; 2005 Apr;102(4):622-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults.
  • OBJECT: The clinical outcome and treatment of adult patients with disseminated intracranial glioblastoma multiforme (GBM) is unclear.
  • The objective in the present study was to assess the prognostic significance of disseminated intracranial GBM in adults at presentation and at the time of tumor progression.
  • Patients with dissemination at first tumor progression (52 patients) overall had a shorter PPS than those in a control group with local progression, after adjusting for age, Kamofsky Performance Scale score, and time from tumor diagnosis to its progression (311 patients).
  • When analyzed according to tumor dissemination type, PPS was significantly shorter in patients with Type II (33 patients, p < 0.01) and Type III spread (11 patients, p < 0.01) but not in those with Type I spread (eight patients, p = 0.18).
  • CONCLUSIONS: Apparently, the presence of intracranial tumor dissemination on initial diagnosis does not in itself preclude aggressive treatment if a patient is otherwise well.
  • [MeSH-major] Brain Neoplasms / pathology. Glioblastoma / pathology. Neoplasm Staging
  • [MeSH-minor] Adult. Aged. Disease Progression. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Prognosis. Retrospective Studies. Survival Analysis

  • Genetic Alliance. consumer health - Glioblastoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15871503.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA13525; United States / NCI NIH HHS / CA / CA82103; United States / NINDS NIH HHS / NS / NS42927
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


23. Ochalski PG, Edinger JT, Horowitz MB, Stetler WR, Murdoch GH, Kassam AB, Engh JA: Intracranial angiomatoid fibrous histiocytoma presenting as recurrent multifocal intraparenchymal hemorrhage. J Neurosurg; 2010 May;112(5):978-82
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial angiomatoid fibrous histiocytoma presenting as recurrent multifocal intraparenchymal hemorrhage.
  • Angiomatoid fibrous histiocytoma (AFH) is a rare soft-tissue neoplasm that most commonly appears in the limbs, typically affecting children and young adults.
  • The tumor has a propensity for local recurrence and recurrent hemorrhage but rarely for remote metastasis.
  • To date, only 2 reports have documented an intracranial occurrence of the tumor (1 of which was believed to be metastatic disease).
  • This is the second report of primary intracranial AFH.
  • Additionally, hemorrhage from an intracranial AFH lesion has yet to be reported, and little is known about the radiographic characteristics and biological behavior of these lesions.
  • In this report, the authors describe the case of a patient with recurrent hemorrhage due to primary multifocal intracranial AFH.
  • Initially misdiagnosed as a cavernous malformation and then an unusual meningioma, the tumor was finally correctly identified when there was a large enough intact resection specimen to reveal the characteristic histological pattern.
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Recurrence. Young Adult

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19731989.001).
  • [ISSN] 1933-0693
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


24. Leonetti JP, Anderson DE, Marzo SJ, Origitano TC, Shirazi M: Intracranial schwannomas of the lower cranial nerves. Otol Neurotol; 2006 Dec;27(8):1142-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial schwannomas of the lower cranial nerves.
  • PATIENTS: All patients with intracranial lower cranial nerve schwannomas treated surgically in our institution between July 1998 and July 2005.
  • INTERVENTION: A retrosigmoid, transcondylar, or combined approach was used for tumor recurrence.
  • RESULTS: Thirty-nine patients underwent surgical resection, with complete tumor removal in 32, near-total resection in 5 patients, and subtotal tumor excision in 2 patients.
  • Long-term (mean, 8.2 years) magnetic resonance imaging surveillance demonstrated recurrent tumor in 2 of 32 complete resections and slow regrowth in 2 of 7 patients with known residual disease.
  • DISCUSSION: Intracranial schwannomas of the lower cranial nerves are relatively uncommon and may present with subtle or no clinical symptoms.
  • Successful surgical resection with low risk of tumor recurrence can be achieved with the retrosigmoid or transcondylar approach.
  • [MeSH-major] Cranial Fossa, Posterior. Cranial Nerve Neoplasms / surgery. Neoplasm Recurrence, Local / surgery. Neurilemmoma / surgery. Skull Base Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Cerebral Angiography. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Otorhinolaryngologic Surgical Procedures. Reoperation. Retrospective Studies. Tomography, X-Ray Computed. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17130803.001).
  • [ISSN] 1531-7129
  • [Journal-full-title] Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
  • [ISO-abbreviation] Otol. Neurotol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


25. Kimura H, Nagatomi A, Ochi M, Kurisu K: Intracranial neurenteric cyst with recurrence and extensive craniospinal dissemination. Acta Neurochir (Wien); 2006 Mar;148(3):347-52; discussion 352
MedlinePlus Health Information. consumer health - Neural Tube Defects.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial neurenteric cyst with recurrence and extensive craniospinal dissemination.
  • We describe a unique intracranial neurenteric cyst with recurrence and dissemination to the spinal cord.
  • [MeSH-major] Brain Neoplasms / pathology. Neoplasm Metastasis / diagnosis. Neoplasm Recurrence, Local / diagnosis. Neural Tube Defects / diagnosis. Spinal Cord Neoplasms / secondary
  • [MeSH-minor] Adult. Diagnosis, Differential. Fatal Outcome. Humans. Magnetic Resonance Imaging. Male. Medulla Oblongata / pathology. Medulla Oblongata / physiopathology. Pons / pathology. Pons / physiopathology. Radiotherapy / methods. Spinal Cord / pathology. Spinal Cord / physiopathology. Subarachnoid Space / pathology. Subarachnoid Space / physiopathology. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16421766.001).
  • [ISSN] 0001-6268
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Austria
  • [Number-of-references] 23
  •  go-up   go-down


26. Metellus P, Nanni I, Dussert C, Trinkhaus M, Fuentes S, Chinot O, Ouafik LH, Fina F, Dufour H, Figarella-Branger D, Grisoli F, Lah TT, Martin PM: [Prognostic implications of biologic markers in intracranial meningiomas: 120 cases]. Neurochirurgie; 2008 Dec;54(6):750-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Prognostic implications of biologic markers in intracranial meningiomas: 120 cases].
  • The recurrence and progression of treated intracranial meningiomas highlights the problem of the type of follow-up that should be used and whether early complementary treatment is indicated.
  • The aim of this study was to evaluate different biochemical markers involved in cell proliferation and transformation to identify new prognostic factors in intracranial meningiomas.
  • Between 1989 and 2003, 120 intracranial meningiomas were studied biochemically.
  • The levels of estrogen receptors (RE), progesterone receptors (RP), cathepsin B (CB), cathepsin L (CL), stefin A (ATA), stefin B (STB), cystatin C (CYSC), urokinase (u-PA), type 1 plasminogen activator inhibitors (PAI-1), cathepsin D (CD) and thymidine kinase activity (TK) were measured in tumor extracts using biochemical assays.
  • Monofactorial analysis showed that expression of progesterone receptors (RP) had an inverse correlation with recurrence (p=0.0025 %) and that thymidine kinase activity (TK), cathepsin L (CL), the WHO grade and the degree of tumor resection correlated with recurrence (p<0.05).
  • The results of this study confirm the importance of biological parameters (PR, CL, TK) as prognostic factors for the risk of recurrence in intracranial meningiomas.
  • [MeSH-major] Meningeal Neoplasms / surgery. Meningioma / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / analysis. Discriminant Analysis. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Prognosis. Retrospective Studies. Young Adult

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18760426.001).
  • [ISSN] 0028-3770
  • [Journal-full-title] Neuro-Chirurgie
  • [ISO-abbreviation] Neurochirurgie
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


27. Osuka S, Tsuboi K, Takano S, Ishikawa E, Matsushita A, Tokuuye K, Akine Y, Matsumura A: Long-term outcome of patients with intracranial germinoma. J Neurooncol; 2007 May;83(1):71-9
MedlinePlus Health Information. consumer health - Childhood Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term outcome of patients with intracranial germinoma.
  • PURPOSE: This study was to clarify the long-term subjective functional state and the therapeutic factors that may influence the outcome and ADL of patients with intracranial germinoma.
  • Recurrence occurred in 5 patients, and 1 patient died of tumor.
  • Radiotherapy administered to the field encompassing the whole ventricle was essential for long-term tumor control.
  • [MeSH-major] Basal Ganglia. Brain Neoplasms / therapy. Germinoma / therapy. Pineal Gland. Pituitary Gland, Posterior
  • [MeSH-minor] Activities of Daily Living. Adolescent. Adult. Chemotherapy, Adjuvant. Child. Combined Modality Therapy. Female. Humans. Incidence. Karnofsky Performance Status. Longitudinal Studies. Magnetic Resonance Imaging. Male. Neoplasm Recurrence, Local / epidemiology. Neoplasm Recurrence, Local / mortality. Neurosurgical Procedures. Surveys and Questionnaires. Survival Analysis. Treatment Outcome

  • Genetic Alliance. consumer health - Germinoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17245622.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


28. Fountas KN, Kapsalaki E, Kassam M, Feltes CH, Dimopoulos VG, Robinson JS, Smith JR: Management of intracranial meningeal hemangiopericytomas: outcome and experience. Neurosurg Rev; 2006 Apr;29(2):145-53

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of intracranial meningeal hemangiopericytomas: outcome and experience.
  • Hemangiopericytomas represent rare intracranial tumors that have a tendency to recur locally and have the unique characteristic of giving extracranial metastases.
  • Preoperative embolization of the tumor was employed in 6/11 patients.
  • All patients underwent craniotomy for tumor resection and postoperative radiation treatment was employed on all but one.
  • Intracranial hemangiopericytomas management requires aggressive surgical resection, postoperative radiation treatment, and extensive follow-up to rule out local recurrences and delayed extracranial metastases.
  • [MeSH-major] Hemangiopericytoma / surgery. Meningeal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / analysis. Diagnostic Imaging. Female. Follow-Up Studies. Glasgow Outcome Scale. Humans. Image Processing, Computer-Assisted. Liver Neoplasms / diagnosis. Liver Neoplasms / secondary. Lung Neoplasms / diagnosis. Lung Neoplasms / secondary. Magnetic Resonance Spectroscopy. Male. Meninges / pathology. Meninges / surgery. Middle Aged. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / pathology. Postoperative Complications / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16391940.001).
  • [ISSN] 0344-5607
  • [Journal-full-title] Neurosurgical review
  • [ISO-abbreviation] Neurosurg Rev
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


29. Korshunov A, Witt H, Hielscher T, Benner A, Remke M, Ryzhova M, Milde T, Bender S, Wittmann A, Schöttler A, Kulozik AE, Witt O, von Deimling A, Lichter P, Pfister S: Molecular staging of intracranial ependymoma in children and adults. J Clin Oncol; 2010 Jul 1;28(19):3182-90
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular staging of intracranial ependymoma in children and adults.
  • PURPOSE: The biologic behavior of intracranial ependymoma is unpredictable on the basis of current staging approaches.
  • [MeSH-major] Brain Neoplasms / genetics. Comparative Genomic Hybridization / methods. Ependymoma / genetics. In Situ Hybridization, Fluorescence / methods
  • [MeSH-minor] Adolescent. Child. Child, Preschool. Chromosome Aberrations. Cohort Studies. Cyclin-Dependent Kinase Inhibitor p16 / genetics. Female. Gene Deletion. Gene Dosage. Humans. Male. Neoplasm Staging. Prognosis. Proportional Hazards Models. Survival Analysis. Young Adult

  • Genetic Alliance. consumer health - Ependymoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Nat Rev Neurol. 2010 Aug;6(8):414 [20718114.001]
  • (PMID = 20516456.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cyclin-Dependent Kinase Inhibitor p16
  •  go-up   go-down


30. Belcadhi M, Mani R, Harzallah M, Bouaouina N, Bouzouita K: [Nasopharyngeal angiofibroma with intracranial extension: situating the chemotherapy-radiotherapy association]. Cancer Radiother; 2008 Sep;12(5):385-8
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Nasopharyngeal angiofibroma with intracranial extension: situating the chemotherapy-radiotherapy association].
  • Nasopharyngeal angiofibroma is a locally aggressive, although histologically benign, vascular neoplasm.
  • This neoplasm accounts for 0.05% of head and neck tumours and affects almost exclusively male adolescents.
  • Other treatment modalities such as radiotherapy and chemotherapy are still recommended for intracranial extension involving the cavernous sinus or the internal carotid artery.
  • We discuss the relevance and outcome of the association chemotherapy-radiotherapy in the treatment of nasopharyngeal angiofibromas with a consistent intracranial extension (stage III B of Arch Otolaryngol Head Neck Surg 122 (2003) 122-129).
  • [MeSH-major] Angiofibroma / drug therapy. Angiofibroma / radiotherapy. Brain Neoplasms / radiotherapy. Nasopharyngeal Neoplasms / drug therapy. Nasopharyngeal Neoplasms / radiotherapy
  • [MeSH-minor] Adult. Female. Humans. Neoplasm Invasiveness

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18339570.001).
  • [ISSN] 1278-3218
  • [Journal-full-title] Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
  • [ISO-abbreviation] Cancer Radiother
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


31. Liu M, Qin W, Yin Z: An unusual case of primary mesenchymal chondrosarcoma in orbit with intracranial extension. Clin Imaging; 2010 Sep-Oct;34(5):379-81
Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An unusual case of primary mesenchymal chondrosarcoma in orbit with intracranial extension.
  • An unusual case of primary orbital mesenchymal chondrosarcoma with intracranial extension is reported, with special emphasis on the radiological findings.
  • [MeSH-major] Brain / pathology. Brain / radiography. Chondrosarcoma, Mesenchymal / diagnosis. Magnetic Resonance Imaging / methods. Orbital Neoplasms / diagnosis. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Adult. Contrast Media. Diagnosis, Differential. Female. Follow-Up Studies. Gadolinium DTPA. Humans. Image Enhancement / methods. Neoplasm Invasiveness. Orbit / pathology. Orbit / radiography. Orbit / surgery. Treatment Outcome

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20813303.001).
  • [ISSN] 1873-4499
  • [Journal-full-title] Clinical imaging
  • [ISO-abbreviation] Clin Imaging
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


32. Barami K: CyberKnife radiosurgery for management of intracranial perineural spread of cutaneous malignancies. J Clin Neurosci; 2010 Oct;17(10):1322-4
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CyberKnife radiosurgery for management of intracranial perineural spread of cutaneous malignancies.
  • Intracranial perineural spread (PNS) is a rare complication of cutaneous malignancies and refers to access of the tumor to the intracranial space typically by tracking along cranial nerves.
  • Radiographic workup showed recurrent tumor involving multiple cranial nerves.
  • To the author's knowledge, these are the first reported patients with intracranial PNS treated via CyberKnife radiosurgery.
  • [MeSH-major] Brain Neoplasms / secondary. Brain Neoplasms / surgery. Cranial Nerves / pathology. Radiosurgery. Skin Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Humans. Magnetic Resonance Imaging / methods. Male. Neoplasm Invasiveness

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Ltd. All rights reserved.
  • (PMID = 20594857.001).
  • [ISSN] 1532-2653
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


33. Liu SJ, Tian DF, He YC: [Correlation between TCM syndrome type and intracranial aggressive potentiality of untreated nasopharyngeal carcinoma]. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Dec;26(12):1086-9
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Correlation between TCM syndrome type and intracranial aggressive potentiality of untreated nasopharyngeal carcinoma].
  • OBJECTIVE: To investigate the correlation between TCM syndrome type and intracranial aggressive potentiality of untreated nasopharyngeal carcinoma (NPC).
  • Correlation between the TCM syndrome type differentiated at the first consultation and the intracranial aggressive potentiality of the primary focus of NPC were analyzed.
  • RESULTS: The incidence of intracranial aggression was significantly higher in patients with Qi-Yin deficiency type than that in those with other two syndrome types during the follow-up period (P < 0.01).
  • CONCLUSION: The intracranial aggessive rate in the untreated NPC patients of Qi-Yin deficiency type was higher than in those of either Qi and blood coagulation type or fire-toxin stagnation type.

  • Genetic Alliance. consumer health - Nasopharyngeal carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17205820.001).
  • [ISSN] 1003-5370
  • [Journal-full-title] Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine
  • [ISO-abbreviation] Zhongguo Zhong Xi Yi Jie He Za Zhi
  • [Language] CHI
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


34. Simon SL, Moonis G, Judkins AR, Scobie J, Burnett MG, Riina HA, Judy KD: Intracranial capillary hemangioma: case report and review of the literature. Surg Neurol; 2005 Aug;64(2):154-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial capillary hemangioma: case report and review of the literature.
  • The authors present an exceedingly rare case of an intracranial capillary hemangioma arising in an adult.
  • The patient underwent a resection of her tumor, which was diagnosed as a capillary hemangioma by histopathologic examination.
  • The patient required 2 further resections after the lesion exhibited a rapid regrowth from residual tumor in the left transverse sinus.
  • CONCLUSIONS: Intracranial capillary hemangiomas are exceedingly rare entities, with a capability for rapid growth.
  • [MeSH-major] Brain Neoplasms / surgery. Hemangioma, Capillary / surgery. Neoplasm Recurrence, Local / surgery. Pregnancy Complications, Neoplastic / surgery
  • [MeSH-minor] Adult. Female. Humans. Pregnancy. Treatment Outcome

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Tumors and Pregnancy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16051010.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


35. George KJ, Price R: Nasoethmoid schwannoma with intracranial extension. Case report and review of literature. Br J Neurosurg; 2009 Feb;23(1):83-5
MedlinePlus Health Information. consumer health - Nasal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nasoethmoid schwannoma with intracranial extension. Case report and review of literature.
  • Only seven cases of nasoethmoid schwannoma with intracranial extension have been reported before and this case is unique in that almost all of the tumour was intracranial.
  • [MeSH-major] Neurilemmoma / pathology. Nose Neoplasms / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Ethmoid Sinus / pathology. Female. Humans. Magnetic Resonance Imaging. Neoplasm Invasiveness. Paranasal Sinus Neoplasms / pathology. Paranasal Sinus Neoplasms / surgery. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Br J Neurosurg. 2009 Dec;23(6):636 [19922281.001]
  • (PMID = 19234915.001).
  • [ISSN] 1360-046X
  • [Journal-full-title] British journal of neurosurgery
  • [ISO-abbreviation] Br J Neurosurg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 3
  •  go-up   go-down


36. Lee YH, Park EK, Park YS, Shim KW, Choi JU, Kim DS: Treatment and outcomes of primary intracranial teratoma. Childs Nerv Syst; 2009 Dec;25(12):1581-7
MedlinePlus Health Information. consumer health - Childhood Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment and outcomes of primary intracranial teratoma.
  • PURPOSE: Until recently, postoperative adjuvant treatment for intracranial teratomas has remained controversial because of the rarity of the tumors and the heterogeneity of histologic types.
  • To define optimal therapy modalities, we retrospectively analyzed the treatment of patients with intracranial teratomas.
  • METHODS: Between 1979 and 2007, 31 patients with intracranial teratomas were treated at our institution.
  • CONCLUSION: Treatment of intracranial teratomas is very difficult because of the heterogeneity of the tumor cells from totipotent origins.
  • [MeSH-major] Brain Neoplasms / therapy. Teratoma / therapy
  • [MeSH-minor] Adolescent. Adult. Chemotherapy, Adjuvant. Child. Child, Preschool. Drug Administration Schedule. Female. Humans. Infant. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Recurrence, Local. Prognosis. Treatment Outcome

  • Genetic Alliance. consumer health - Teratoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19693515.001).
  • [ISSN] 1433-0350
  • [Journal-full-title] Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
  • [ISO-abbreviation] Childs Nerv Syst
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


37. Ramirez C, Delrieu O, Mineo JF, Paradot G, Allaoui M, Dubois F, Blond S: Intracranial dissemination of primary spinal cord anaplastic oligodendroglioma. Eur J Neurol; 2007 May;14(5):578-80
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial dissemination of primary spinal cord anaplastic oligodendroglioma.
  • We report the first case of a 22-year-old man, with a previously neurosurgically treated intramedullary anaplastic oligodendroglioma (World Health Organization grade III), who developed 19 months later two histologically proven intracranial metastases.
  • [MeSH-major] Brain Neoplasms / secondary. Neoplasm Metastasis / physiopathology. Oligodendroglioma / secondary. Spinal Cord Neoplasms / pathology. Subarachnoid Space / physiopathology
  • [MeSH-minor] Adult. Cerebellar Neoplasms / secondary. Fatal Outcome. Humans. Hydrocephalus / etiology. Hydrocephalus / physiopathology. Hydrocephalus / therapy. Lateral Ventricles / pathology. Lateral Ventricles / physiopathology. Male. Neurosurgical Procedures / adverse effects

  • Genetic Alliance. consumer health - Anaplastic Oligodendroglioma.
  • Genetic Alliance. consumer health - Oligodendroglioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17437621.001).
  • [ISSN] 1468-1331
  • [Journal-full-title] European journal of neurology
  • [ISO-abbreviation] Eur. J. Neurol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


38. Hua W, Xu F, Mao Y, Zhang J, Wang Y, Mao R, Zhou L: Primary intracranial leiomyomas: Report of two cases and review of the literature. Clin Neurol Neurosurg; 2009 Dec;111(10):907-12
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary intracranial leiomyomas: Report of two cases and review of the literature.
  • A leiomyoma is a benign neoplasm composed of smooth muscle cells that commonly occurs in the genitourinary and gastrointestinal tracts.
  • Primary intracranial leiomyoma, however, is extremely rare and only a few cases have been reported to date.
  • In this study, we present two cases of primary intracranial leiomyomas in middle-aged men.
  • [MeSH-major] Brain Neoplasms / pathology. Leiomyoma / pathology
  • [MeSH-minor] Adult. Biomarkers. Craniotomy. Eosinophils / pathology. Humans. Immunohistochemistry. Magnetic Resonance Imaging. Male. Middle Aged. Nerve Tissue Proteins / metabolism. Neurosurgical Procedures. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19740596.001).
  • [ISSN] 1872-6968
  • [Journal-full-title] Clinical neurology and neurosurgery
  • [ISO-abbreviation] Clin Neurol Neurosurg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Nerve Tissue Proteins
  •  go-up   go-down


39. Hayashi Y, Shima H, Kita D, Kinoshita M, Yoshida Y, Hasegawa M, Hamada J: Intracranial extension of meibomian gland carcinoma with pagetoid changes. J Clin Neurosci; 2009 Apr;16(4):568-70
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial extension of meibomian gland carcinoma with pagetoid changes.
  • The tumor was almost totally removed.
  • Despite surgery and local irradiation, intracranial metastases were recognized one year later, and the patient underwent total tumor removal and whole-brain irradiation.
  • Although multiple lung metastases were detected one year after the second operation, three years post-surgery he remains free of intracranial tumor recurrence.
  • Early diagnosis and appropriate treatment are essential to improve the prognosis of patients with meibomian gland carcinoma with intracranial extension.
  • [MeSH-major] Eyelid Neoplasms / complications. Meibomian Glands / pathology. Sebaceous Gland Neoplasms / complications
  • [MeSH-minor] Adult. Humans. Lung Neoplasms / secretion. Male. Neoplasm Invasiveness

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19200735.001).
  • [ISSN] 0967-5868
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


40. Li DR, Ishikawa T, Zhao D, Michiue T, Quan L, Zhu BL, Maeda H: Unexpected sudden death due to intracranial chordoma: an autopsy case. Forensic Sci Int; 2010 Jul 15;200(1-3):e15-8
Genetic Alliance. consumer health - Chordoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unexpected sudden death due to intracranial chordoma: an autopsy case.
  • Intracranial chordoma is a locally invasive, relatively rare tumour at the base of the skull.
  • We report an autopsy case of a sudden unexpected death due to clinically undiagnosed intracranial chordoma in the brainstem without haemorrhage.
  • Even a minor intracranial tumour that is not primarily life-threatening may cause sudden death due to subsequent obstructive hydrocephalus.
  • [MeSH-major] Brain Stem Neoplasms / pathology. Chordoma / pathology. Death, Sudden / etiology
  • [MeSH-minor] Adult. Brain / pathology. Forensic Pathology. Humans. Hydrocephalus / etiology. Male. Neoplasm Invasiveness

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2010 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 20444561.001).
  • [ISSN] 1872-6283
  • [Journal-full-title] Forensic science international
  • [ISO-abbreviation] Forensic Sci. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


41. Thompson EM, Sather MD, Reyes CA, Long DJ: Intracranial leptomeningeal metastasis from thymic carcinoma: case report and review. Surg Neurol; 2007 Aug;68(2):233-8
MedlinePlus Health Information. consumer health - Thymus Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial leptomeningeal metastasis from thymic carcinoma: case report and review.
  • BACKGROUND: Thymic carcinoma is an uncommon malignant tumor of the anterior mediastinum.
  • Meningeal metastasis from this type of neoplasm is extraordinarily rare and the prognosis is abysmal.
  • CONCLUSION: The authors report a case of intracranial meningeal metastasis from a lymphoepithelioma-like poorly differentiated metastatic thymic carcinoma, which was treated by resection and WBRT.
  • [MeSH-major] Carcinoma / secondary. Meningeal Neoplasms / secondary. Thymus Neoplasms / pathology
  • [MeSH-minor] Adult. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17537485.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 20
  •  go-up   go-down


42. Gao F, You T, Lü JY, Wang YJ: [Research on the expression of cancer associated gene in the intracranial tumors]. Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 May;37(3):424-6
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Research on the expression of cancer associated gene in the intracranial tumors].
  • OBJECTIVE: To investigate the function significance and application value of cancer associated gene (CAGE) in the pathogenesis of intracranial tumors.
  • CONCLUSION: The CAGE plays important role in the pathogenesis of glioma, and may act as the tumor specific antigen for glioma.
  • [MeSH-major] Brain Neoplasms / genetics. DEAD-box RNA Helicases / biosynthesis. Glioma / genetics. Meningioma / genetics
  • [MeSH-minor] Adult. Antigens, Neoplasm / biosynthesis. Antigens, Neoplasm / genetics. Female. Humans. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16761424.001).
  • [ISSN] 1672-173X
  • [Journal-full-title] Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
  • [ISO-abbreviation] Sichuan Da Xue Xue Bao Yi Xue Ban
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; EC 3.6.1.- / DDX53 protein, human; EC 3.6.4.13 / DEAD-box RNA Helicases
  •  go-up   go-down


43. DeMonte F, Hanna E: Transmaxillary exploration of the intracranial portion of the maxillary nerve in malignant perineural disease. Technical note. J Neurosurg; 2007 Sep;107(3):672-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transmaxillary exploration of the intracranial portion of the maxillary nerve in malignant perineural disease. Technical note.
  • OBJECT: Achieving microscopically tumor-free margins during resection of skull base malignancies has consistently been identified as a positive prognostic factor for patient survival.
  • When malignancies extend perineurally into the major nerves traversing the skull base and entering the cavernous sinus, achieving tumor-free margins can be challenging and typically necessitates performing a craniotomy to access the lateral wall of the cavernous sinus.
  • This report describes a novel technique used to access and resect malignancy extending perineurally into the intracranial portion of V2 via the maxillary sinus.
  • METHODS: Seven patients with maxillary sinus tumors and perineural extensions along V2, who underwent resection of the primary tumor and transmaxillary intracranial exposure and dissection of the maxillary nerve to achieve maximal tumor resection, were analyzed.
  • No intracranial or cavernous sinus disease was present.
  • CONCLUSIONS: This technique extended the limits of resection without the need for a craniotomy and improved local tumor control in this patient cohort.
  • [MeSH-major] Carcinoma / pathology. Carcinoma / surgery. Dissection / methods. Maxillary Nerve / surgery. Maxillary Sinus Neoplasms / pathology. Maxillary Sinus Neoplasms / surgery
  • [MeSH-minor] Adult. Cohort Studies. Humans. Male. Neoplasm Invasiveness. Retrospective Studies. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17886571.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


44. Elsharkawy AA, Kamal EM, Tawfik A, Zaher A, Kasem M: Juvenile nasopharyngeal angiofibroma with intracranial extension: analysis of 23 Egyptian patients. Int J Pediatr Otorhinolaryngol; 2010 Jul;74(7):755-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Juvenile nasopharyngeal angiofibroma with intracranial extension: analysis of 23 Egyptian patients.
  • The purpose of this study was to present our experience with definitive surgical management of patients with Juvenile nasopharyngeal angiofibroma with intracranial extension.
  • Complete resection of the tumor was achieved in 19 patients with residual or recurrence in four patients.
  • The subcranial transfacial transmaxillary approach avoids the complications of craniotomy and provides adequate access for excision of Juvenile nasopharyngeal angiofibroma with intracranial extradural extension.
  • [MeSH-major] Angiofibroma / surgery. Nasopharyngeal Neoplasms / surgery. Otorhinolaryngologic Surgical Procedures / methods
  • [MeSH-minor] Adolescent. Child. Cranial Fossa, Anterior / pathology. Cranial Fossa, Anterior / surgery. Cranial Fossa, Middle / pathology. Cranial Fossa, Middle / surgery. Egypt. Embolization, Therapeutic. Gelatin Sponge, Absorbable. Hemostatics. Humans. Male. Maxillary Artery. Neoplasm Invasiveness. Postoperative Complications. Preoperative Care. Retrospective Studies. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 20394990.001).
  • [ISSN] 1872-8464
  • [Journal-full-title] International journal of pediatric otorhinolaryngology
  • [ISO-abbreviation] Int. J. Pediatr. Otorhinolaryngol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Hemostatics
  •  go-up   go-down


45. Nguyen QN, Chang EL, Allen PK, Maor MH, Ater JL, Mahajan A, Wolff JE, Weinberg JS, Woo SY: Focal and craniospinal irradiation for patients with intracranial germinoma and patterns of failure. Cancer; 2006 Nov 1;107(9):2228-36
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Focal and craniospinal irradiation for patients with intracranial germinoma and patterns of failure.
  • BACKGROUND: The authors compared the patterns of failure in patients with intracranial germinoma who were managed with either chemotherapy and focal irradiation or with craniospinal irradiation (CSI).
  • METHODS: A retrospective review was conducted on 21 patients with intracranial germinoma and treated with radiotherapy (RT) to the central nervous system at The University of Texas M. D.
  • [MeSH-major] Brain Neoplasms / radiotherapy. Cranial Irradiation. Germinoma / radiotherapy. Spinal Cord / pathology. Spinal Neoplasms / radiotherapy
  • [MeSH-minor] Adolescent. Adult. Child. Disease-Free Survival. Female. Humans. Male. Neoplasm Recurrence, Local. Radiotherapy, High-Energy. Retrospective Studies. Survival Rate. Treatment Failure

  • Genetic Alliance. consumer health - Germinoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2006 American Cancer Society.
  • (PMID = 17019739.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


46. Duntsch C, Zhou Q, Weimar JD, Frankel B, Robertson JH, Pourmotabbed T: Up-regulation of neuropoiesis generating glial progenitors that infiltrate rat intracranial glioma. J Neurooncol; 2005 Feb;71(3):245-55
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Up-regulation of neuropoiesis generating glial progenitors that infiltrate rat intracranial glioma.
  • To investigate adult neural stem cell (NSC) biology in relation to glioma, the C6 glioma cell line was tagged with green fluorescent protein (GFP) and inoculated into the brain of adult rats.
  • Nestin immunoreactive cells were found infiltrating glioma, but the distribution of abnormal immunoreactivity was restricted to the dorsal and medial border of the tumor relative to the ipsilateral ventricle.
  • Furthermore, a dense contiguous population of nestin immunoreactive cells could be found streaming from ipsilateral dorsal tip of the SVZ, tracking along the ventral margin of the corpus callosum, and fanning out to encompass and infiltrate the proximal tumor border.
  • Although most cells were either nestin or glial fibrillary acidic protein (GFAP) immunoreactive in the SVZ and along the ventral margin of the corpus callosum, the number of cells co-expressing both markers increased proportionally as the tumor was approached so that the predominant cell population along the proximal tumor border was GFAP immunoreactive.
  • In summary, there is an induction of neuropoietic activity in a rat intracranial glioma model that results in an infiltration and accumulation of abnormal nestin and GFAP expressing cells with proliferative potential along the dorsal and medial border of intracranial C6 glioma.
  • [MeSH-major] Brain Neoplasms / metabolism. Brain Neoplasms / pathology. Glioma / metabolism. Glioma / pathology. Neuroglia / metabolism. Neuroglia / pathology. Stem Cells / metabolism
  • [MeSH-minor] Animals. Cell Differentiation. Cell Lineage. Cell Movement. Cerebral Ventricles / pathology. Disease Models, Animal. Fluorescent Antibody Technique. Glial Fibrillary Acidic Protein / metabolism. Immunohistochemistry. Intermediate Filament Proteins / metabolism. Neoplasm Transplantation. Nerve Tissue Proteins / metabolism. Nestin. Rats. Rats, Inbred WF. Rats, Sprague-Dawley. Up-Regulation

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Stem Cells.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15735912.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Glial Fibrillary Acidic Protein; 0 / Intermediate Filament Proteins; 0 / Nerve Tissue Proteins; 0 / Nes protein, rat; 0 / Nestin
  •  go-up   go-down


47. Buhl R, Nabavi A, Wolff S, Hugo HH, Alfke K, Jansen O, Mehdorn HM: MR spectroscopy in patients with intracranial meningiomas. Neurol Res; 2007 Jan;29(1):43-6
Hazardous Substances Data Bank. LACTIC ACID .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MR spectroscopy in patients with intracranial meningiomas.
  • Apart from the known spectra and metabolites such as choline, creatine and N-acetyl-aspartate (NAA), recent publications have shown that lactate is often found in necrotic tumor tissue.
  • Within a 2 year period, 39 patients with an intracranial meningioma were studied with MRS.
  • [MeSH-major] Magnetic Resonance Spectroscopy / methods. Meningeal Neoplasms / diagnosis. Meninges / pathology. Meningioma / diagnosis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / analysis. Biomarkers, Tumor / metabolism. Diagnosis, Differential. Female. Humans. Lactic Acid / analysis. Lactic Acid / metabolism. Magnetic Resonance Imaging / methods. Male. Middle Aged. Neoplasm Invasiveness / diagnosis. Neoplasm Recurrence, Local / diagnosis. Predictive Value of Tests. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17427274.001).
  • [ISSN] 0161-6412
  • [Journal-full-title] Neurological research
  • [ISO-abbreviation] Neurol. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 33X04XA5AT / Lactic Acid
  •  go-up   go-down


48. Plotkin M, Amthauer H, Eisenacher J, Wurm R, Michel R, Wust P, Stockhammer F, Röttgen R, Gutberlet M, Ruf J, Felix R: Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours. Neuroradiology; 2005 Jan;47(1):18-26
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours.
  • In the current study we investigated whether IMT-SPECT could also be useful in the follow-up of brain metastases and other intracranial tumours of non-astrocytic origin.
  • The study included 22 patients with suspected recurrent intracranial tumours of non-astrocytic origin (12 brain metastases, one supratentorial primitive neuroendocrine tumour (PNET), one rhabdoid tumour, two clivus chordomas, three ependymomas, two pituitary tumours, one anaplastic meningioma) who had previously been treated by surgery and/or radio/chemotherapy.
  • We concluded that the IMT-SPECT is a promising complementary imaging tool for the detection of recurrences of non-astrocytic intracranial tumours and their distinguishing from treatment-induced changes.
  • [MeSH-major] Brain Neoplasms / radionuclide imaging. Iodine Radioisotopes. Methyltyrosines. Neoplasm Recurrence, Local / radionuclide imaging. Radiopharmaceuticals. Tomography, Emission-Computed, Single-Photon / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Chordoma / radionuclide imaging. Ependymoma / radionuclide imaging. False Negative Reactions. False Positive Reactions. Female. Follow-Up Studies. Glioma / radionuclide imaging. Humans. Magnetic Resonance Imaging. Male. Meningioma / radionuclide imaging. Middle Aged. Neuroendocrine Tumors / radionuclide imaging. Pituitary Neoplasms / radionuclide imaging. Retrospective Studies. Rhabdoid Tumor / radionuclide imaging. Sensitivity and Specificity. Supratentorial Neoplasms / radionuclide imaging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15630586.001).
  • [ISSN] 0028-3940
  • [Journal-full-title] Neuroradiology
  • [ISO-abbreviation] Neuroradiology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Iodine Radioisotopes; 0 / Methyltyrosines; 0 / Radiopharmaceuticals; 14684-02-7 / 3-iodo-alpha-methyltyrosine
  •  go-up   go-down


49. Erdoğan N, Tucer B, Mavili E, Menkü A, Kurtsoy A: Ultrasound guidance in intracranial tumor resection: correlation with postoperative magnetic resonance findings. Acta Radiol; 2005 Nov;46(7):743-9
Hazardous Substances Data Bank. GADOLINIUM, ELEMENTAL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ultrasound guidance in intracranial tumor resection: correlation with postoperative magnetic resonance findings.
  • PURPOSE: To determine the inter-method agreement between intraoperative ultrasonography and postoperative contrast-enhanced magnetic resonance imaging (MRI) in detecting tumor residue.
  • Any echogenic region >5 mm in thickness extending from the surgical cavity into the brain substance was taken as the sonographic criterion for residual tumor.
  • CONCLUSION: Intraoperative ultrasound is an effective tool for maximizing the extent of intracranial tumor resection.
  • [MeSH-major] Brain Neoplasms / surgery. Brain Neoplasms / ultrasonography. Magnetic Resonance Imaging. Neoplasm, Residual / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Contrast Media. Female. Gadolinium. Glioblastoma / surgery. Humans. Intraoperative Period. Male. Middle Aged. Postoperative Period. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16372696.001).
  • [ISSN] 0284-1851
  • [Journal-full-title] Acta radiologica (Stockholm, Sweden : 1987)
  • [ISO-abbreviation] Acta Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Sweden
  • [Chemical-registry-number] 0 / Contrast Media; AU0V1LM3JT / Gadolinium
  •  go-up   go-down


50. Zengin E, Atukeren P, Kokoglu E, Gumustas MK, Zengin U: Alterations in lipid peroxidation and antioxidant status in different types of intracranial tumors within their relative peritumoral tissues. Clin Neurol Neurosurg; 2009 May;111(4):345-51
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Alterations in lipid peroxidation and antioxidant status in different types of intracranial tumors within their relative peritumoral tissues.
  • OBJECTIVES: Elevated levels of lipid peroxidation and changes in the concentration of enzymatic and non-enzymatic antioxidant systems have been reported in various cancers, but there are very few reports available of lipid peroxidation due to oxidative stress in patients with intracranial neoplasms.
  • PATIENTS AND METHODS: We investigated the extent of oxidative stress and the levels of antioxidants in 16 astrocytomas and 38 other different types intracranial tumors comparing the results with their corresponding peritumoral tissues and comparing the levels in between low-grade and high-grade tumors.
  • The extent of lipid peroxidation as evidenced by the formation of thiobarbituric acid-reacting substances (TBARS), as well as the status of the antioxidant systems such as superoxide dismutase (SOD), glutathione reductase (GR) and reduced glutathione (GSH) in tumor tissues and adjacent peritumoral tissues was estimated.
  • RESULTS: According to our results lipid peroxidation in brain tumor tissues was enhanced compared to the corresponding adjacent peritumoral tissues.
  • The low levels of antioxidants in tumor tissues, might be related to an increased use of antioxidant systems to scavenge lipid peroxides.
  • [MeSH-major] Antioxidants / metabolism. Astrocytoma / metabolism. Astrocytoma / pathology. Brain Neoplasms / metabolism. Brain Neoplasms / pathology. Lipid Peroxidation. Oxidative Stress
  • [MeSH-minor] Adult. Aged. Analysis of Variance. Disease Progression. Glutathione / metabolism. Glutathione Reductase / metabolism. Humans. Meningioma / metabolism. Meningioma / pathology. Middle Aged. Neoplasm Staging / methods. Spectrophotometry. Superoxide Dismutase / metabolism. Thiobarbituric Acid Reactive Substances / metabolism. Up-Regulation

  • MedlinePlus Health Information. consumer health - Antioxidants.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19117666.001).
  • [ISSN] 1872-6968
  • [Journal-full-title] Clinical neurology and neurosurgery
  • [ISO-abbreviation] Clin Neurol Neurosurg
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antioxidants; 0 / Thiobarbituric Acid Reactive Substances; EC 1.15.1.1 / Superoxide Dismutase; EC 1.8.1.7 / Glutathione Reductase; GAN16C9B8O / Glutathione
  •  go-up   go-down


51. Rousseau A, Bernier M, Kujas M, Varlet P: Primary intracranial melanocytic tumor simulating pituitary macroadenoma: case report and review of the literature. Neurosurgery; 2005 Aug;57(2):E369; discussion E369
MedlinePlus Health Information. consumer health - Pituitary Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary intracranial melanocytic tumor simulating pituitary macroadenoma: case report and review of the literature.
  • OBJECTIVE AND IMPORTANCE: Primary intracranial melanocytic tumors are rare lesions, sellar ones being even more exceptional.
  • INTERVENTION: A gross subtotal resection of a hemorrhagic tumor was performed.
  • Histological examination revealed melanin-laden pleomorphic tumor cells that tested positive for HMB-45 and S-100 and negative for cytokeratins, thus demonstrating that the tumor was a melanocytic neoplasm.
  • CONCLUSION: Primary sellar melanocytic neoplasms are extremely rare lesions and present with few differential diagnoses.
  • Deciding whether the tumor is best classified as a melanocytoma or a melanoma may prove difficult.
  • [MeSH-major] Adenoma / diagnosis. Melanoma / surgery. Meningeal Neoplasms / surgery. Pituitary Neoplasms / surgery
  • [MeSH-minor] Adult. Antigens, Neoplasm. Female. Humans. Melanoma-Specific Antigens. Neoplasm Proteins / metabolism. S100 Proteins / metabolism

  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16094139.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Melanoma-Specific Antigens; 0 / Neoplasm Proteins; 0 / S100 Proteins
  • [Number-of-references] 27
  •  go-up   go-down


52. Chacko G, Chacko AG, Rajshekhar V, Muliyil JP: Intracranial hemangiopericytomas: correlation of topoisomerase IIalpha expression with biologic behavior. Surg Neurol; 2006 Jan;65(1):11-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial hemangiopericytomas: correlation of topoisomerase IIalpha expression with biologic behavior.
  • The aim of this study was to correlate the topoisomerase IIalpha proliferation index (TPI) with biologic behavior in intracranial hemangiopericytomas.
  • METHODS: Clinical, radiological, and management data in 27 patients with intracranial hemangiopericytoma admitted between 1990 and 2003 were reviewed.
  • A radical excision of tumor was done in 18, subtotal excision in 2, partial excision in 4, and a biopsy in 3 patients.
  • Tumor recurrence was noted in 15 (55.6%) of the 27 patients (mean follow-up duration, 51.5 months).
  • [MeSH-major] Antigens, Neoplasm / metabolism. DNA Topoisomerases, Type II / metabolism. DNA-Binding Proteins / metabolism. Meningeal Neoplasms / enzymology. Meningeal Neoplasms / pathology. Meningioma / enzymology. Meningioma / pathology
  • [MeSH-minor] Adolescent. Adult. Biomarkers, Tumor / metabolism. Child. Disease-Free Survival. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / enzymology. Neoplasm Recurrence, Local / pathology. Predictive Value of Tests. Prognosis. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16378841.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / DNA-Binding Proteins; EC 5.99.1.3 / DNA Topoisomerases, Type II; EC 5.99.1.3 / DNA topoisomerase II alpha
  •  go-up   go-down


53. Do L, Pezner R, Radany E, Liu A, Staud C, Badie B: Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases. Int J Radiat Oncol Biol Phys; 2009 Feb 1;73(2):486-91
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.
  • RESULTS: Between December 1999 and January 2007, 30 patients diagnosed with intracranial metastases were treated with resection followed by SRS or SRT to the resection cavity.
  • Of the 30 patients, 4 (13.3%) developed recurrence in the resection cavity, and 19 (63%) developed recurrences in new intracranial sites.
  • [MeSH-major] Brain Neoplasms / secondary. Brain Neoplasms / surgery. Neoplasm Recurrence, Local / surgery. Radiosurgery / methods. Salvage Therapy / methods
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Cranial Irradiation / adverse effects. Disease-Free Survival. Dose Fractionation. Female. Humans. Male. Middle Aged. Radiotherapy, Adjuvant. Retrospective Studies. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18922650.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


54. Schmalisch K, Beschorner R, Psaras T, Honegger J: Postoperative intracranial seeding of craniopharyngiomas--report of three cases and review of the literature. Acta Neurochir (Wien); 2010 Feb;152(2):313-9; discussion 319
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Postoperative intracranial seeding of craniopharyngiomas--report of three cases and review of the literature.
  • Postoperative MRI showed no evidence of residual tumor.
  • Two years later, MRI revealed a local recurrence and in addition a separated cystic tumor on the right side adjacent to the middle cerebral artery consistent with seeding along the surgical route.
  • On histopathological examination, both, the local recurrent tumor and the distant deposit turned out to be adamantinomatous craniopharyngiomas.
  • Two years later, MRI revealed a right fronto-lateral intracranial metastasis at the site of the former craniotomy, which was removed by re-craniotomy.
  • This deposit in the operative pathway was found to be an adamantinomatous craniopharyngioma, as was the initial tumor.
  • The recent control MRT revealed a right parietal intracranial tumor with peripheral contrast enhancement, which was located distant to the former craniotomy.
  • The tumor was removed and histopathological examination revealed an adamantinomatous craniopharyngioma in accordance with the initial tumor.
  • Ectopic recurrence of craniopharyngioma suggests that meticulous protection of the whole surgical field and careful handling of the tumor during the operation are required.
  • [MeSH-major] Brain Neoplasms / secondary. Craniopharyngioma / secondary. Neoplasm Metastasis / pathology. Neoplasm Seeding. Pituitary Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Craniotomy. Female. Frontal Bone / pathology. Frontal Bone / surgery. Humans. Magnetic Resonance Imaging. Male. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / surgery. Parietal Bone / pathology. Parietal Bone / surgery. Reoperation. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19859655.001).
  • [ISSN] 0942-0940
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Austria
  • [Number-of-references] 31
  •  go-up   go-down


55. Weon YC, Kim EY, Kim HJ, Byun HS, Park K, Kim JH: Intracranial solitary fibrous tumors: imaging findings in 6 consecutive patients. AJNR Am J Neuroradiol; 2007 Sep;28(8):1466-9
MedlinePlus Health Information. consumer health - MRI Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial solitary fibrous tumors: imaging findings in 6 consecutive patients.
  • BACKGROUND AND PURPOSE: Intracranial solitary fibrous tumors (ISFTs) are rare mesenchymal neoplasms originating in the meninges.
  • The aim of this study was to describe the CT, MR imaging, and angiographic features of the solitary fibrous tumor and to identify imaging characteristics.
  • We evaluated the size, shape, and location of the tumor; the internal content and margin of the lesion; the pattern of enhancement; and the change of the adjacent structures.
  • All of the tumors had thickening of the meninges adjacent to the tumor.
  • Angiography showed delayed tumor blushing in all, and 3 of them had dysplastic dilation of the tumor vessels.
  • CONCLUSION: Although there are no pathognomonic imaging findings, some imaging features, such as the "black-and-white mixed" pattern on T2-weighted images and marked heterogeneous enhancement, might be helpful in the diagnosis of intracranial solitary fibrous tumor.
  • [MeSH-major] Angiography, Digital Subtraction. Brain Neoplasms / diagnosis. Cerebral Angiography. Magnetic Resonance Imaging. Neoplasms, Fibrous Tissue / diagnosis. Tomography, X-Ray Computed
  • [MeSH-minor] Adult. Female. Humans. Male. Middle Aged. Neoplasm Invasiveness / diagnosis. Retrospective Studies. Skull

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17846192.001).
  • [ISSN] 0195-6108
  • [Journal-full-title] AJNR. American journal of neuroradiology
  • [ISO-abbreviation] AJNR Am J Neuroradiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


56. Chang Q, Pang JC, Li KK, Poon WS, Zhou L, Ng HK: Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors. Hum Pathol; 2005 Dec;36(12):1265-72
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors.
  • Medulloblastomas (MBs) and supratentorial primitive neuroectodermal tumors (SPNETs) are histologically alike intracranial PNETs found in different anatomical locations of the brain.
  • The aim of this study was to investigate whether promoter hypermethylation of putative tumor suppressor genes was involved in both types of intracranial PNETs.
  • In conclusion, our study demonstrates that promoter hypermethylation of RASSF1A is a common event in intracranial PNETs, whereas FHIT and sFRP1 are epigenetically affected in a fraction of SPNETs.
  • [MeSH-major] Acid Anhydride Hydrolases / genetics. Brain Neoplasms / genetics. Cell Cycle Proteins / genetics. DNA Methylation. Neoplasm Proteins / genetics. Neuroectodermal Tumors, Primitive / genetics. Protein-Serine-Threonine Kinases / genetics. Tumor Suppressor Proteins / genetics
  • [MeSH-minor] Adolescent. Adult. Aged. Ataxia Telangiectasia Mutated Proteins. Cell Line, Tumor. Child. Child, Preschool. DNA Primers / chemistry. DNA, Neoplasm / analysis. Female. Humans. Infant. Male. Reverse Transcriptase Polymerase Chain Reaction

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16311119.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cell Cycle Proteins; 0 / DNA Primers; 0 / DNA, Neoplasm; 0 / Neoplasm Proteins; 0 / RASSF1 protein, human; 0 / Tumor Suppressor Proteins; 0 / fragile histidine triad protein; EC 2.7.11.1 / ATR protein, human; EC 2.7.11.1 / Ataxia Telangiectasia Mutated Proteins; EC 2.7.11.1 / Protein-Serine-Threonine Kinases; EC 3.6.- / Acid Anhydride Hydrolases
  •  go-up   go-down


57. Liu SJ, Sun YM, Tian DF, He YC, Zeng L, He Y, Ling CQ, Sun SH: Downregulated NM23-H1 expression is associated with intracranial invasion of nasopharyngeal carcinoma. Br J Cancer; 2008 Jan 29;98(2):363-9
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Downregulated NM23-H1 expression is associated with intracranial invasion of nasopharyngeal carcinoma.
  • Because the focus of nasopharyngeal carcinoma (NPC) is very close to intracranial organs, it often makes incursions into cranial cavity.
  • Identification of intracranial invasion-associated indicators will provide potential therapeutic targets for NPC patients with intracranial invasion.
  • In this regard, Human Xpro HC-plus cancer-related gene chip was utilised to screen intracranial invasion-associated genes for NPC from the biopsied primary focus tissue samples.
  • [MeSH-major] Brain Neoplasms / secondary. Carcinoma / genetics. Carcinoma / pathology. NM23 Nucleoside Diphosphate Kinases / genetics. Nasopharyngeal Neoplasms / genetics. Nasopharyngeal Neoplasms / pathology
  • [MeSH-minor] Adult. Animals. Antineoplastic Agents / pharmacology. Antineoplastic Agents / therapeutic use. Berberine / pharmacology. Berberine / therapeutic use. Down-Regulation / drug effects. Drug Evaluation, Preclinical. Female. Gene Expression Profiling. Gene Expression Regulation, Neoplastic / drug effects. Humans. Male. Mice. Mice, Nude. Middle Aged. Neoplasm Invasiveness. Oligonucleotide Array Sequence Analysis. Tumor Cells, Cultured

  • Genetic Alliance. consumer health - Nasopharyngeal carcinoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Lett. 2000 Jan 1;148(1):19-25 [10680588.001]
  • [Cites] Cancer Lett. 2007 Aug 8;253(1):74-88 [17320280.001]
  • [Cites] Eur J Pharmacol. 2000 Apr 14;394(2-3):171-9 [10771282.001]
  • [Cites] Mol Cell Biol. 2001 Jul;21(14):4713-24 [11416147.001]
  • [Cites] Gastroenterology. 2001 Dec;121(6):1339-47 [11729113.001]
  • [Cites] J Bioenerg Biomembr. 2000 Jun;32(3):237-46 [11768307.001]
  • [Cites] Carcinogenesis. 2002 May;23(5):867-76 [12016162.001]
  • [Cites] Cell. 2003 Mar 7;112(5):659-72 [12628186.001]
  • [Cites] J Cancer Res Clin Oncol. 2003 Jul;129(7):410-4 [12819961.001]
  • [Cites] Zhong Xi Yi Jie He Xue Bao. 2004 Jul;2(4):262-4 [15339409.001]
  • [Cites] Planta Med. 1975 Dec;28(4):353-8 [1208684.001]
  • [Cites] Cancer Res. 1987 Jun 15;47(12):3239-45 [2438036.001]
  • [Cites] J Natl Cancer Inst. 1988 Apr 6;80(3):200-4 [3346912.001]
  • [Cites] Cancer Res. 1988 Nov 15;48(22):6550-4 [2460224.001]
  • [Cites] Cell. 1991 Apr 5;65(1):25-35 [2013093.001]
  • [Cites] Cancer Res. 1993 May 1;53(9):1971-3 [8481897.001]
  • [Cites] Bull Cancer. 1993 Aug;80(8):717-22 [8204954.001]
  • [Cites] J Biol Chem. 1997 Feb 28;272(9):5525-32 [9038158.001]
  • [Cites] Neuroradiology. 1997 Oct;39(10):741-6 [9351114.001]
  • [Cites] Br J Cancer. 1998;77(1):1-10 [9459138.001]
  • [Cites] Life Sci. 1998;62(25):2283-94 [9651117.001]
  • [Cites] Br J Cancer. 1999 Jul;80(9):1420-6 [10424745.001]
  • [Cites] Carcinogenesis. 2005 Feb;26(2):281-91 [15498789.001]
  • [Cites] Biochimie. 2005 Mar-Apr;87(3-4):307-14 [15781317.001]
  • [Cites] Clin Cancer Res. 2005 Oct 15;11(20):7264-72 [16243796.001]
  • [Cites] Biomed Pharmacother. 2005 Oct;59 Suppl 2:S268-71 [16507390.001]
  • [Cites] Cancer Cell. 2006 Mar;9(3):209-23 [16530705.001]
  • [Cites] J Cancer Res Clin Oncol. 2007 Feb;133(2):71-81 [16941191.001]
  • [Cites] Zhonghua Er Bi Yan Hou Ke Za Zhi. 1997 Apr;32(2):99-102 [10743138.001]
  • (PMID = 18219290.001).
  • [ISSN] 0007-0920
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Validation Studies
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / NM23 Nucleoside Diphosphate Kinases; 0I8Y3P32UF / Berberine; EC 2.7.4.6 / NME1 protein, human
  • [Other-IDs] NLM/ PMC2361469
  •  go-up   go-down


58. Shim KW, Kim TG, Suh CO, Cho JH, Yoo CJ, Choi JU, Kim JH, Kim DS: Treatment failure in intracranial primary germinomas. Childs Nerv Syst; 2007 Oct;23(10):1155-61
MedlinePlus Health Information. consumer health - Childhood Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment failure in intracranial primary germinomas.
  • OBJECT: A radiation dose of 40-50 Gy is able to produce a cure rate of more than 90% in intracranial pure germinoma.
  • Tumor recurrence was closely related to the volume of radiation but not to the dose of radiation.
  • If the tumor bed and craniospinal axis were fully covered, the radiation dose might be reduced.
  • Chemotherapy alone showed earlier recurrence and a higher tumor recurrence rate.
  • [MeSH-major] Brain Neoplasms / therapy. Germinoma / therapy
  • [MeSH-minor] Adolescent. Adult. Antineoplastic Agents / therapeutic use. Child. Child, Preschool. Combined Modality Therapy. Dose-Response Relationship, Radiation. Female. Humans. Infant. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Recurrence, Local. Neurosurgical Procedures. Survival Analysis. Tomography, X-Ray Computed. Treatment Failure

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17610071.001).
  • [ISSN] 0256-7040
  • [Journal-full-title] Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
  • [ISO-abbreviation] Childs Nerv Syst
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


59. Uesaka T, Shono T, Suzuki SO, Nakamizo A, Niiro H, Mizoguchi M, Iwaki T, Sasaki T: Expression of VEGF and its receptor genes in intracranial schwannomas. J Neurooncol; 2007 Jul;83(3):259-66
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of VEGF and its receptor genes in intracranial schwannomas.
  • In this study, we determined the expression levels of VEGF, and vascular endothelial growth factor receptor (VEGFR)-1 and -2 mRNA in 46 intracranial schwannomas by quantitative real-time PCR, and correlated these with various clinical factors or other molecular markers.
  • When we divided patients into two groups according to VEGF mRNA expression in the tumor, there was no significant difference in patient age, gender, or cranial nerves of origin between groups; however, the tumor volume tended to be larger in the high VEGF group than in the low VEGF group.
  • Based on these observations, the significance of VEGF and its receptor genes in intracranial schwannomas is discussed.
  • [MeSH-major] Brain Neoplasms / genetics. Gene Expression Regulation, Neoplastic. Neurilemmoma / genetics. Vascular Endothelial Growth Factor A / genetics. Vascular Endothelial Growth Factor Receptor-1 / genetics. Vascular Endothelial Growth Factor Receptor-2 / genetics
  • [MeSH-minor] Adult. Aged. Antigens, Neoplasm / metabolism. Astrocytoma / genetics. Astrocytoma / metabolism. Astrocytoma / pathology. Cranial Nerve Neoplasms / genetics. Cranial Nerve Neoplasms / metabolism. Cranial Nerve Neoplasms / pathology. DNA Topoisomerases, Type II / metabolism. DNA-Binding Proteins / metabolism. Female. Glioblastoma / genetics. Glioblastoma / metabolism. Glioblastoma / pathology. Humans. Immunoenzyme Techniques. Male. Meningioma / genetics. Meningioma / metabolism. Meningioma / pathology. Middle Aged. Neoplasm Recurrence, Local / genetics. Neoplasm Recurrence, Local / metabolism. Neoplasm Recurrence, Local / pathology. Neurofibromin 2 / genetics. RNA, Messenger / metabolism. RNA, Neoplasm / genetics. RNA, Neoplasm / metabolism. Reverse Transcriptase Polymerase Chain Reaction / methods. Ubiquitin-Protein Ligases / metabolism

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17570036.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / DNA-Binding Proteins; 0 / Neurofibromin 2; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / VEGFA protein, human; 0 / Vascular Endothelial Growth Factor A; EC 2.7.10.1 / Vascular Endothelial Growth Factor Receptor-1; EC 2.7.10.1 / Vascular Endothelial Growth Factor Receptor-2; EC 5.99.1.3 / DNA Topoisomerases, Type II; EC 5.99.1.3 / DNA topoisomerase II alpha; EC 6.3.2.19 / MIB1 ligase, human; EC 6.3.2.19 / Ubiquitin-Protein Ligases
  •  go-up   go-down


60. Yang JJ, Xiang Y, Yang XY, Wan XR, Wang RZ, Ren ZY, Yin HM, Guo WD, Ou XM: [Evaluation of emergency craniotomy for the treatment of patients with intracranial metastases of choriocarcinoma]. Zhonghua Fu Chan Ke Za Zhi; 2005 May;40(5):335-8
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Evaluation of emergency craniotomy for the treatment of patients with intracranial metastases of choriocarcinoma].
  • OBJECTIVE: To study the diagnosis, management and prognosis of intracranial metastases of gestational trophoblastic tumour (GTT) patients who had emergency surgical decompression due to highly increased intracranial pressure.
  • METHODS: Ninety-three patients with intracranial metastases of gestational trophoblastic tumour were hospitalized in our department of Peking Union Medical College Hospital from 1985 to 2004.
  • Thirteen of them who underwent emergency craniotomy were retrospectively analyzed, and all of them presented with raised intracranial pressure and intracerebral haemorrhagic mass.
  • An undetermined intracranial haemorrhage in young female patients of reproductive age group should raise the suspicion of cerebral metastatic choriocarcinoma.
  • [MeSH-major] Choriocarcinoma / surgery. Uterine Neoplasms / surgery
  • [MeSH-minor] Adult. Craniotomy. Female. Humans. Neoplasm Metastasis. Retrospective Studies. Young Adult

  • Genetic Alliance. consumer health - Choriocarcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15938786.001).
  • [ISSN] 0529-567X
  • [Journal-full-title] Zhonghua fu chan ke za zhi
  • [ISO-abbreviation] Zhonghua Fu Chan Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


61. Sell M, Huber-Schumacher S, van Landeghem FK: Congenital glioblastoma multiforme with abnormal vascularity presenting as intracranial hemorrhage in prenatal ultrasound. Childs Nerv Syst; 2006 Jul;22(7):729-33
MedlinePlus Health Information. consumer health - Fetal Health and Development.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Congenital glioblastoma multiforme with abnormal vascularity presenting as intracranial hemorrhage in prenatal ultrasound.
  • BACKGROUND: A rare case of a congenital brain neoplasm with intratumoral massive hemorrhage suggested by prenatal ultrasound examination in a 32-week gestational age male fetus is reported.
  • METHODS: Autopsy disclosed a large well-delimited tumor with a sponge-like appearance due to high vascularization, which involved nearly the whole left cerebral hemisphere and led to marked hydrocephalus by secondary aqueductal stenosis.
  • FINDINGS: The present case demonstrates that malignant congenital neoplasms should be considered in the differential diagnosis of fetal intracranial hemorrhage.
  • [MeSH-major] Brain Neoplasms / ultrasonography. Fetal Diseases / ultrasonography. Glioblastoma / ultrasonography. Intracranial Hemorrhages / ultrasonography. Ultrasonography, Prenatal / methods
  • [MeSH-minor] Adult. Female. Fetus. Humans. Male. Pregnancy

  • Genetic Alliance. consumer health - Glioblastoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16673148.001).
  • [ISSN] 0256-7040
  • [Journal-full-title] Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
  • [ISO-abbreviation] Childs Nerv Syst
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


62. Terterov S, Krieger MD, Bowen I, McComb JG: Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas. J Neurosurg Pediatr; 2010 Aug;6(2):131-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
  • OBJECT: The objective of this study was to determine the role of intracranial CSF examination in detecting true cases of early tumor dissemination.
  • However, the value of examining intracranial CSF cytology in detecting early dissemination is uncertain.
  • RESULTS: Between lumbar and intracranial CSF cytology results, 7 of 40 were discordant: in 2 intracranial CSF was negative and lumbar CSF was positive, and in 5 the reverse was true.
  • Between MR imaging and intracranial CSF cytology results, 8 of 52 were discordant: in 3 intracranial CSF was negative and MR imaging was positive, and in 5 the reverse was true.
  • Patients with positive and negative results on intracranial CSF cytology had a median survival of 31 and 31.4 months, respectively (p = 0.84).
  • CONCLUSIONS: Discordance exists between the results of neuraxis MR imaging and lumbar and intracranial CSF cytology in perioperative detection of tumor dissemination for pediatric medulloblastoma, supratentorial PNETs, and ependymoma.
  • In 1 case in this series, perioperative dissemination was detected by intracranial CSF cytology, but not by lumbar CSF cytology or neuraxis MR imaging.
  • Isolated intracranial CSF cytology positivity may represent an earlier stage of disseminated disease.
  • Complementary use of perioperative neuraxis MR imaging and lumbar and intracranial CSF cytology can reduce the incidence of missed diagnoses of dissemination.
  • Survival analysis revealed that perioperative neuraxis MR imaging findings are correlated with survival, whereas perioperative lumbar and intracranial CSF cytology findings are not.
  • [MeSH-major] Cerebellar Neoplasms / pathology. Cerebrospinal Fluid / cytology. Ependymoma / pathology. Medulloblastoma / pathology. Neuroectodermal Tumors, Primitive / pathology. Supratentorial Neoplasms / pathology
  • [MeSH-minor] Adolescent. Brain / pathology. Brain / surgery. Cerebellum / pathology. Cerebellum / surgery. Chemotherapy, Adjuvant. Child. Child, Preschool. Combined Modality Therapy. Female. Follow-Up Studies. Humans. Infant. Kaplan-Meier Estimate. Magnetic Resonance Imaging. Male. Neoplasm Staging. Predictive Value of Tests. Radiotherapy, Adjuvant. Survival Rate. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20672933.001).
  • [ISSN] 1933-0715
  • [Journal-full-title] Journal of neurosurgery. Pediatrics
  • [ISO-abbreviation] J Neurosurg Pediatr
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


63. Valentinis L, Tuniz F, Valent F, Mucchiut M, Little D, Skrap M, Bergonzi P, Zanchin G: Headache attributed to intracranial tumours: a prospective cohort study. Cephalalgia; 2010 Apr;30(4):389-98
MedlinePlus Health Information. consumer health - Headache.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Headache attributed to intracranial tumours: a prospective cohort study.
  • Between January 2007 and March 2008, we prospectively studied all patients operated on for intracranial tumours in our Department of Neurosurgery.
  • If headache improved postoperatively, a diagnosis of 'headache attributed to intracranial neoplasm' was made, according to the 2004 International Classification of Headache Disorders (ICHD-II).
  • Intracranial tumour headache was non-specific and in most cases could not be classified by current ICHD-II diagnostic criteria for primary headache syndromes.
  • [MeSH-major] Brain Neoplasms / epidemiology. Brain Neoplasms / pathology. Headache / epidemiology. Headache / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Cohort Studies. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Multivariate Analysis. Prevalence. Prospective Studies. Risk Factors. Young Adult

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Cephalalgia. 2010 Apr;30(4):387-8 [20511198.001]
  • (PMID = 19673912.001).
  • [ISSN] 1468-2982
  • [Journal-full-title] Cephalalgia : an international journal of headache
  • [ISO-abbreviation] Cephalalgia
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


64. Trippa F, Maranzano E, Costantini S, Giorni C: Hypofractionated stereotactic radiotherapy for intracranial meningiomas: preliminary results of a feasible trial. J Neurosurg Sci; 2009 Mar;53(1):7-11
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hypofractionated stereotactic radiotherapy for intracranial meningiomas: preliminary results of a feasible trial.
  • The authors report preliminary results of a feasible trial on hypofractionated stereotactic radiotherapy (hFSRT) in patients (pts) with intracranial meningiomas.
  • METHODS: From August 2003 to May 2007, 35 consecutive pts with a median age of 59 years (range, 23-86) underwent hFSRT for intracranial meningiomas.
  • CONCLUSIONS: These preliminary data suggest that hFSRT is a safe and effective treatment modality for intracranial meningiomas.
  • [MeSH-major] Brain Neoplasms / radiotherapy. Meningioma / radiotherapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Dose Fractionation. Feasibility Studies. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Staging. Stereotaxic Techniques. Treatment Outcome. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19322130.001).
  • [ISSN] 0390-5616
  • [Journal-full-title] Journal of neurosurgical sciences
  • [ISO-abbreviation] J Neurosurg Sci
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


65. Karmakar S, Olive MF, Banik NL, Ray SK: Intracranial stereotaxic cannulation for development of orthotopic glioblastoma allograft in Sprague-Dawley rats and histoimmunopathological characterization of the brain tumor. Neurochem Res; 2007 Dec;32(12):2235-42
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial stereotaxic cannulation for development of orthotopic glioblastoma allograft in Sprague-Dawley rats and histoimmunopathological characterization of the brain tumor.
  • Glioblastoma is the most common brain tumor that causes significant mortality annually.
  • In the present investigation, we successfully implanted rat C6 cells via intracranial stereotaxic cannulation in adult Sprague-Dawley rats for development and histoimmunopathological characterization of an advanced orthotopic glioblastoma allograft model, which could be useful for investigating the course of glioblastoma development as well as for testing efficacy of new therapeutic agents.
  • The orthotopic glioblastoma allograft was generated by intracerebral injection of rat C6 cells through a guide-cannula system and after 21 post-inoculation days the brain tumor was characterized by histoimmunopathological experiments.
  • Our investigation indicated the successful development of intracranial cannulated orthotopic glioblastoma allograft in adult Sprague-Dawley rats, making it as a useful animal model of glioblastoma for pre-clinical evaluation of various therapeutic strategies for the management of glioblastoma.
  • [MeSH-major] Brain Neoplasms / pathology. Glioblastoma / pathology. Neoplasm Transplantation / methods
  • [MeSH-minor] Animals. Biomarkers, Tumor. Catheterization / methods. Cell Transplantation / instrumentation. Cell Transplantation / methods. Coloring Agents. Fluorescent Antibody Technique. Immunohistochemistry. In Situ Hybridization. Male. Rats. Rats, Sprague-Dawley. Stereotaxic Techniques

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17701349.001).
  • [ISSN] 0364-3190
  • [Journal-full-title] Neurochemical research
  • [ISO-abbreviation] Neurochem. Res.
  • [Language] eng
  • [Grant] United States / NCRR NIH HHS / RR / C06 RR015455; United States / NINDS NIH HHS / NS / NS-57811; United States / NCI NIH HHS / CA / R01 CA-91460
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Coloring Agents
  •  go-up   go-down


66. Lützen U, Engellandt K: [Late distant metastases of intracranial hemangiopericytomas]. Rontgenpraxis; 2006;56(3):93-7
MedlinePlus Health Information. consumer health - CT Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Late distant metastases of intracranial hemangiopericytomas].
  • The treatment of both, the primary tumor as well as the recurrence and the distant metastases is radical surgery.
  • The post-operative radiation therapy improves the local control of the tumor.
  • [MeSH-major] Abdominal Neoplasms / radiography. Abdominal Neoplasms / secondary. Brain Neoplasms / radiography. Hemangiopericytoma / radiography. Hemangiopericytoma / secondary. Neoplasm Recurrence, Local / radiography. Tomography, X-Ray Computed
  • [MeSH-minor] Adult. Female. Humans

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17051963.001).
  • [ISSN] 0035-7820
  • [Journal-full-title] Röntgenpraxis; Zeitschrift für radiologische Technik
  • [ISO-abbreviation] Rontgenpraxis
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


67. Aguirre-Quezada DE, Martínez-Anda JJ, Aguilar-Ayala EL, Chávez-Macías L, Olvera-Rabiela JE: [Intracranial and intramedullary peripheral nerve sheath tumours. Case reports from 20 autopsies]. Rev Neurol; 2006 Aug 16-31;43(4):197-200
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intracranial and intramedullary peripheral nerve sheath tumours. Case reports from 20 autopsies].
  • INTRODUCTION: Tumors arising from the sheath of peripheral nerves, both intracranial and intraspinal, are uncommon and are sometimes of difficult clinical diagnosis, especially when they occur in unusual sites.
  • Histological malignancy of this neoplasm is rare.
  • MATERIALS AND METHODS: The clinical and pathological findings of 20 autopsy cases of intracranial and intraspinal peripheral nerve tumors are analyzed.
  • The importance of early detection on intracranial and intraspinal peripheral tumors is paramount, since the large size of these histologically benign neoplasms makes them biologically malignant.
  • [MeSH-major] Brain Neoplasms / pathology. Cranial Nerve Neoplasms / pathology. Nerve Sheath Neoplasms / pathology. Spinal Cord Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Autopsy. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Neurilemmoma / pathology. Neurofibromatosis 1 / pathology. Neurofibromatosis 2 / pathology. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16883507.001).
  • [ISSN] 0210-0010
  • [Journal-full-title] Revista de neurologia
  • [ISO-abbreviation] Rev Neurol
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


68. Yokoi K, Akiyama M, Yanagisawa T, Yoshino M, Nakazaki H, Takahashi K, Takahashi-Fujigasaki J, Kanetsuna Y, Yamada H, Oi S, Eto Y: RNA expression analysis of a congenital intracranial teratoma. Pediatr Blood Cancer; 2005 May;44(5):516-20
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] RNA expression analysis of a congenital intracranial teratoma.
  • Congenital intracranial tumors are extremely rare and account only for 0.5%-1.5% of brain tumors in children.
  • We report a large intrauterine congenital teratoma in a female fetus at gestation weeks 37, which was diagnosed by detecting the tumor and associated craniomegaly with ultrasonography (US) and magnetic resonance (MR) imaging.
  • The tumor had replaced the cerebral hemispheres and produced prenatal manifestations.
  • [MeSH-major] Brain Neoplasms / diagnosis. Gene Expression Regulation, Neoplastic. Teratoma / diagnosis
  • [MeSH-minor] Adult. Diagnostic Imaging. Female. Fetal Diseases / diagnosis. Fetus. Gene Expression Profiling. Humans. Oligonucleotide Array Sequence Analysis. Pregnancy. RNA, Neoplasm / analysis

  • Genetic Alliance. consumer health - Teratoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15558703.001).
  • [ISSN] 1545-5009
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Neoplasm
  •  go-up   go-down


69. Bassiouni H, Asgari S, Hübschen U, König HJ, Stolke D: Intracranial hemangiopericytoma: treatment outcomes in a consecutive series. Zentralbl Neurochir; 2007 Aug;68(3):111-8
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial hemangiopericytoma: treatment outcomes in a consecutive series.
  • OBJECTIVE: The purpose of this study was to analyse a series of patients harbouring an intracranial hemangiopericytoma (HPC) with respect to clinical presentation, treatment results and long-term follow-up outcomes.
  • [MeSH-major] Brain Neoplasms / surgery. Hemangiopericytoma / surgery. Neurosurgical Procedures
  • [MeSH-minor] Adult. Diagnostic Imaging. Epilepsy / etiology. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Metastasis / pathology. Neoplasm Recurrence, Local. Retrospective Studies. Survival. Treatment Outcome

  • Genetic Alliance. consumer health - Hemangiopericytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17665341.001).
  • [ISSN] 0044-4251
  • [Journal-full-title] Zentralblatt für Neurochirurgie
  • [ISO-abbreviation] Zentralbl. Neurochir.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


70. Abe T, Kamida T, Goda M, Inoue R, Fujiki M, Kobayashi H, Hatano Y, Shibuya H, Fujiwara S, Terashi H, Mori T: Intracranial infiltration by recurrent scalp dermatofibrosarcoma protuberans. J Clin Neurosci; 2009 Oct;16(10):1358-60
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial infiltration by recurrent scalp dermatofibrosarcoma protuberans.
  • [MeSH-major] Dermatofibrosarcoma / surgery. Neoplasm Recurrence, Local / surgery. Scalp / pathology. Skin Neoplasms / surgery
  • [MeSH-minor] Humans. Magnetic Resonance Imaging. Male. Radiosurgery / methods. Young Adult

  • Genetic Alliance. consumer health - Dermatofibrosarcoma Protuberans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19560926.001).
  • [ISSN] 0967-5868
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


71. Scotland JL, Al-Shahi Salman R, Deary IJ, Whittle IR: Recruitment difficulties in brain tumour patients cause participation bias: findings from a neuropsychological study of adult inpatients with supratentorial intracranial tumours. Acta Neurochir (Wien); 2009 Oct;151(10):1191-5
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recruitment difficulties in brain tumour patients cause participation bias: findings from a neuropsychological study of adult inpatients with supratentorial intracranial tumours.
  • METHODS: We compared the characteristics of patients with intracranial tumours who participated in a psychological study of inspection time with the characteristics of patients who did not participate for a number of reasons.
  • RESULTS: Of 178 newly diagnosed adults with intracranial tumours, 136 (76%) were eligible, of whom 76 (56%) participated and 34 (25%) declined.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19440655.001).
  • [ISSN] 0942-0940
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] ENG
  • [Grant] United Kingdom / Medical Research Council / / G0700704; United Kingdom / Medical Research Council / / G108/613; United Kingdom / Chief Scientist Office / / CZH/4/232
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Austria
  •  go-up   go-down


72. Sajja R, Barnett GH, Lee SY, Harnisch G, Stevens GH, Lee J, Suh JH: Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary results. Technol Cancer Res Treat; 2005 Dec;4(6):675-82
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary results.
  • The purpose of this study was to evaluate tumor control, complications, and outcome from intensity-modulated radiation therapy (IMRT) for intracranial meningiomas.
  • Between July 1997 and November 2003, patients with intracranial meningiomas were treated at our institution with the NOMOS Peacock system utilizing the Multileaf Intensity Modulating Collimator (MIMiC).
  • The median tumor dose was 50.4 Gy prescribed to the 87% isodose line providing a median target coverage of 95%.
  • In conclusion, intensity-modulated radiation therapy is a safe and effective treatment for some intracranial meningiomas.
  • A greater number of patients with longer follow-up after treatment may be needed to determine treatment variables predicting for long-term tumor control.
  • [MeSH-major] Meningeal Neoplasms / radiotherapy. Meningioma / radiotherapy. Neoplasm Recurrence, Local / radiotherapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Combined Modality Therapy. Cranial Irradiation. Disease-Free Survival. Female. Follow-Up Studies. Humans. Male. Middle Aged. Radiosurgery. Radiotherapy, Conformal. Retrospective Studies. Salvage Therapy. Survival Rate. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16292888.001).
  • [ISSN] 1533-0346
  • [Journal-full-title] Technology in cancer research & treatment
  • [ISO-abbreviation] Technol. Cancer Res. Treat.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


73. Milker-Zabel S, Zabel A, Schulz-Ertner D, Schlegel W, Wannenmacher M, Debus J: Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors. Int J Radiat Oncol Biol Phys; 2005 Mar 1;61(3):809-16
Genetic Alliance. consumer health - Meningioma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors.
  • PURPOSE: To analyze our long-term experience and prognostic factors after fractionated stereotactic radiotherapy (FSRT) in patients with benign or atypical intracranial meningioma.
  • METHODS AND MATERIALS: Between January 1985 and December 2001, 317 patients with a median age of 55.7 years were treated with FSRT for intracranial meningioma.
  • The tumor distribution was World Health Organization (WHO) Grade 1 in 48.3%, WHO Grade 2 in 8.2%, and unknown in 43.5%.
  • The overall local tumor control rate was 93.1% (295 of 317).
  • At a median of 4.5 years after FSRT, 22 patients (6.9%) had local tumor progression on MRI.
  • Local tumor failure was significantly greater in patients with WHO Grade 2 meningioma (p <0.002) than in patients with WHO Grade 1 or unknown histologic features.
  • Patients with a tumor volume >60 cm(3) had a recurrence rate of 15.5% vs. 4.3% for those with a tumor volume of < or =60 cm(3) (p <0.001).
  • We identified the tumor volume, indication for FSRT, and histologic features of the meningioma as statistically significant prognostic factors.
  • [MeSH-major] Meningeal Neoplasms / radiotherapy. Meningioma / radiotherapy
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Disease Progression. Dose Fractionation. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / radiotherapy. Prognosis. Radiotherapy Planning, Computer-Assisted. Stereotaxic Techniques. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15708260.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


74. Hamlat A, Saikali S, Chaperon J, Carsin-Nicol B, Calve ML, Lesimple T, Ben-hassel M, Guegan Y: Proposal of a scoring scale as a survival predictor in intracranial oligodendrogliomas. J Neurooncol; 2006 Sep;79(2):159-68
MedlinePlus Health Information. consumer health - Childhood Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Proposal of a scoring scale as a survival predictor in intracranial oligodendrogliomas.
  • CONCLUSIONS: Our scale is a plausible way of classifying patients harboring intracranial OD according to expected survival.
  • [MeSH-major] Brain Neoplasms / classification. Brain Neoplasms / pathology. Oligodendroglioma / classification. Oligodendroglioma / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Chromosomes, Human, Pair 1 / genetics. Diagnosis-Related Groups. Female. Gene Deletion. Gene Expression Regulation, Neoplastic. Humans. Male. Middle Aged. Multivariate Analysis. Necrosis. Neoplasm Staging. Predictive Value of Tests. Prognosis. Proportional Hazards Models. Statistics, Nonparametric. Survival Analysis

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16821091.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


75. Olson C, Yen CP, Schlesinger D, Sheehan J: Radiosurgery for intracranial hemangiopericytomas: outcomes after initial and repeat Gamma Knife surgery. J Neurosurg; 2010 Jan;112(1):133-9
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiosurgery for intracranial hemangiopericytomas: outcomes after initial and repeat Gamma Knife surgery.
  • OBJECT: Intracranial hemangiopericytoma is a rare CNS tumor that exhibits a high incidence of local recurrence and distant metastasis.
  • The purpose of this study was to evaluate the role of Gamma Knife surgery (GKS) in the management of intracranial hemangiopericytomas.
  • RESULTS: At last follow-up, local tumor control was demonstrated in 47.6% of the patients (10 of 21 patients) with hemangiopericytomas.
  • Prior fractionated irradiation or radiosurgical prescription dose did not correlate with tumor control.
  • [MeSH-major] Brain Neoplasms / surgery. Hemangiopericytoma / surgery. Neoplasm Recurrence, Local / surgery. Radiosurgery / methods
  • [MeSH-minor] Adult. Craniotomy / methods. Disease Progression. Embolization, Therapeutic. Female. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Metastasis. Radiotherapy / methods. Radiotherapy Dosage. Sphenoid Bone / surgery. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19392594.001).
  • [ISSN] 1933-0693
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


76. Preusser M, Wolfsberger S, Haberler C, Breitschopf H, Czech T, Slavc I, Harris AL, Acker T, Budka H, Hainfellner JA: Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival. Acta Neuropathol; 2005 Feb;109(2):211-6
MedlinePlus Health Information. consumer health - Childhood Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival.
  • We investigated angiogenic patterns and expression of hypoxia-related tissue factors and their prognostic impact in 100 cases of intracranial ependymoma.
  • HIF-1alpha expression occurs in a significantly smaller fraction of cases and only in a few tumor cells without clear association with necrosis.
  • We conclude that bizarre vascular pattern, necrosis and high hypoxia score are frequently detectable in intracranial ependymoma, but seem less important for patient outcome than tumor cell proliferation.
  • [MeSH-major] Antigens, Neoplasm / metabolism. Brain Neoplasms / metabolism. Carbonic Anhydrases / metabolism. Ependymoma / metabolism. Neovascularization, Pathologic. Transcription Factors / metabolism
  • [MeSH-minor] Adolescent. Adult. Aged. Antigens, CD34 / metabolism. Child. Child, Preschool. Female. Gene Expression Regulation, Neoplastic / physiology. Humans. Hypoxia-Inducible Factor 1, alpha Subunit. Immunohistochemistry / methods. In Situ Hybridization / methods. Infant. Male. Middle Aged. Regression Analysis. Retrospective Studies. Survival Analysis. Time Factors. Vascular Endothelial Growth Factor A / genetics. Vascular Endothelial Growth Factor A / metabolism

  • Genetic Alliance. consumer health - Ependymoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15614581.001).
  • [ISSN] 0001-6322
  • [Journal-full-title] Acta neuropathologica
  • [ISO-abbreviation] Acta Neuropathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antigens, CD34; 0 / Antigens, Neoplasm; 0 / HIF1A protein, human; 0 / Hypoxia-Inducible Factor 1, alpha Subunit; 0 / Transcription Factors; 0 / Vascular Endothelial Growth Factor A; EC 4.2.1.1 / CA9 protein, human; EC 4.2.1.1 / Carbonic Anhydrases
  •  go-up   go-down


77. Fernandes AL, Ratilal B, Mafra M, Magalhaes C: Aggressive intracranial and extra-cranial epithelioid hemangioendothelioma: a case report and review of the literature. Neuropathology; 2006 Jun;26(3):201-5
Hazardous Substances Data Bank. GADOLINIUM, ELEMENTAL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aggressive intracranial and extra-cranial epithelioid hemangioendothelioma: a case report and review of the literature.
  • Epithelioid hemangioendothelioma is a rare tumor of intermediate malignancy.
  • Twelve intracranial cases have been well documented.
  • The neoplasm was isointense with gray matter in both T1 and T2-weighted images, showing marked nodular gadolinium enhancement.
  • About 90% of the tumor was surgically removed.
  • The neoplasm was fibrous, well defined and arose from the left temporal artery branches.
  • We report a unique and extremely aggressive tumor.
  • [MeSH-major] Brain Neoplasms / pathology. Hemangioendothelioma, Epithelioid / pathology. Skull Base Neoplasms / pathology
  • [MeSH-minor] Adult. Fatal Outcome. Gadolinium. Humans. Immunohistochemistry. Magnetic Resonance Imaging. Male. Neoplasm Invasiveness / pathology. Radiographic Image Enhancement

  • Genetic Alliance. consumer health - Hemangioendothelioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16771175.001).
  • [ISSN] 0919-6544
  • [Journal-full-title] Neuropathology : official journal of the Japanese Society of Neuropathology
  • [ISO-abbreviation] Neuropathology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] AU0V1LM3JT / Gadolinium
  •  go-up   go-down


78. Ogawa K, Yoshii Y, Shikama N, Nakamura K, Uno T, Onishi H, Itami J, Shioyama Y, Iraha S, Hyodo A, Toita T, Kakinohana Y, Tamaki W, Ito H, Murayama S: Spinal recurrence from intracranial germinoma: risk factors and treatment outcome for spinal recurrence. Int J Radiat Oncol Biol Phys; 2008 Dec 1;72(5):1347-54
MedlinePlus Health Information. consumer health - Childhood Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spinal recurrence from intracranial germinoma: risk factors and treatment outcome for spinal recurrence.
  • PURPOSE: To analyze retrospectively the risk factors of spinal recurrence in patients with intracranial germinoma and clinical outcomes of patients who developed spinal recurrence.
  • Multivariate analysis revealed that large intracranial disease (>/=4 cm) and multifocal intracranial disease were independent risk factors for spinal recurrence.
  • In the analysis, presence of intracranial recurrence and salvage treatment modality (radiotherapy with chemotherapy vs. radiotherapy alone) had a statistically significant impact on DFS.
  • The 3-year DFS rate in patients with no intracranial recurrence and treated with both spinal radiotherapy and chemotherapy was 100%, whereas only 17% in patients with intracranial recurrence or treated with radiotherapy alone (p = 0.001).
  • CONCLUSION: Large intracranial disease and multifocal intracranial disease were risk factors for spinal recurrence in patients with intracranial germinoma with no evidence of spinal metastases at diagnosis.
  • [MeSH-major] Brain Neoplasms / pathology. Brain Neoplasms / radiotherapy. Germinoma / pathology. Germinoma / radiotherapy. Neoplasm Recurrence, Local / radiotherapy. Spinal Cord Neoplasms / secondary. Spinal Neoplasms / secondary
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Chorionic Gonadotropin / blood. Female. Humans. Japan. Magnetic Resonance Imaging. Male. Radiotherapy Dosage. Recurrence. Retrospective Studies. Risk Factors. Young Adult

  • Genetic Alliance. consumer health - Germinoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18513888.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Chorionic Gonadotropin
  •  go-up   go-down


79. Mermanishvili TL, Dzhorbenadze TA, Chachia GG: [Association of the degree of differentiation and the mitotic activity of intracranial meningiomas with age and gender]. Arkh Patol; 2010 May-Jun;72(3):16-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Association of the degree of differentiation and the mitotic activity of intracranial meningiomas with age and gender].
  • Intensive work is under way to detect the direct and indirect signs that can be used to predict the behavior of a tumor process with greater or lesser assurance.
  • The authors have studied different aspects of the clinical course and recurrence of intracranial meningiomas, investigated the morphological features of their individual forms, their mitotic activity and, on this basis, considered the degree of differentiation and prediction of a recurrence.
  • [MeSH-major] Meningeal Neoplasms / pathology. Meningioma / pathology. Mitosis
  • [MeSH-minor] Adult. Age Factors. Aged. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Prognosis. Sex Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20734827.001).
  • [ISSN] 0004-1955
  • [Journal-full-title] Arkhiv patologii
  • [ISO-abbreviation] Arkh. Patol.
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


80. Nagulić M, Tukić L, Ilić S, Marković M: [Intracranial menigioma manifested after delivery in a patient with Hodgkin's disease]. Vojnosanit Pregl; 2006 Mar;63(3):305-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intracranial menigioma manifested after delivery in a patient with Hodgkin's disease].
  • BACKGROUND: Intracranial meningioma is rerely reported in the patients treated for Hodgkin's disease (HD), known to mainly occur in the area of radiation therapy.
  • CASE REPORT: A 26-year-old woman with HD, and intracranial meningioma following the delivery, was presented.
  • Three years prior the surgery for intracranial tumor, the patient had been started to be treated for HD of neoplasm stage I (NS I) type, by the use of the standard (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone) BEA-COPP protocol.
  • Two days following the normal delivery, during the acute disorder of the consciousness, intracranial tumor was found.
  • CONCLUSION: there were no reliable signs of the use of an intensive hemotherapy in the reported case (alkylating cytostatics and topoisomerases inhibitors) which might have caused the proliferation of a benign solid tumor.
  • On the basis of the significant psychic disorders before the pregnancy, as well as upon the size of the operated on tumor, we concluded that the occurrence of intracranial meningioma could be regarded the parallel neoplastic disease or the second primary tumor.
  • [MeSH-major] Hodgkin Disease. Meningeal Neoplasms. Meningioma. Pregnancy Complications, Neoplastic
  • [MeSH-minor] Adult. Female. Humans. Neoplasms, Second Primary / diagnosis. Pregnancy

  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • MedlinePlus Health Information. consumer health - Tumors and Pregnancy.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16605198.001).
  • [ISSN] 0042-8450
  • [Journal-full-title] Vojnosanitetski pregled
  • [ISO-abbreviation] Vojnosanit Pregl
  • [Language] srp
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Serbia and Montenegro
  •  go-up   go-down


81. Chan WS, Zhang J, Khong PL: 18F-FDG-PET-CT imaging findings of recurrent intracranial haemangiopericytoma with distant metastases. Br J Radiol; 2010 Aug;83(992):e172-4
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] 18F-FDG-PET-CT imaging findings of recurrent intracranial haemangiopericytoma with distant metastases.
  • A 42-year-old woman presented with local recurrence and distant lung and liver metastases 7 years after resection of a primary intracranial haemangiopericytoma.
  • [MeSH-major] Brain Neoplasms / radionuclide imaging. Hemangiopericytoma / radionuclide imaging. Liver Neoplasms / secondary. Neoplasm Recurrence, Local / radionuclide imaging
  • [MeSH-minor] Adult. Female. Fluorodeoxyglucose F18. Humans. Positron-Emission Tomography / methods. Radiopharmaceuticals. Tomography, X-Ray Computed / methods

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Jpn J Clin Oncol. 2001 Nov;31(11):548-52 [11773263.001]
  • [Cites] J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9 [11895036.001]
  • [Cites] Tumori. 2004 Mar-Apr;90(2):265-8 [15237597.001]
  • [Cites] Radiology. 1987 Aug;164(2):521-6 [3496626.001]
  • [Cites] Aust N Z J Med. 1991 Dec;21(6):884-5 [1818550.001]
  • [Cites] Acta Neuropathol. 1994;88(5):454-8 [7531384.001]
  • [Cites] Neurosurg Rev. 2006 Apr;29(2):145-53 [16391940.001]
  • [Cites] Am J Surg Pathol. 1997 Nov;21(11):1354-60 [9351573.001]
  • [Cites] J Clin Gastroenterol. 1997 Dec;25(4):706-8 [9451701.001]
  • [Cites] J Comput Assist Tomogr. 1999 May-Jun;23(3):365-8 [10348440.001]
  • [Cites] World J Gastroenterol. 2005 Jul 21;11(27):4281-4 [16015707.001]
  • [Cites] Clin Nucl Med. 2005 Nov;30(11):717-20 [16237292.001]
  • [Cites] AJNR Am J Neuroradiol. 1996 Aug;17(7):1365-71 [8871726.001]
  • (PMID = 20675461.001).
  • [ISSN] 1748-880X
  • [Journal-full-title] The British journal of radiology
  • [ISO-abbreviation] Br J Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  • [Other-IDs] NLM/ PMC3473511
  •  go-up   go-down


82. Muhonen MG, Bierman JS, Hussain NS, Hanley HA, Hussain SS: Giant intracranial teratoma and lack of cortical development in a fetus. Case report. J Neurosurg; 2005 Aug;103(2 Suppl):180-3
MedlinePlus Health Information. consumer health - Fetal Health and Development.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant intracranial teratoma and lack of cortical development in a fetus. Case report.
  • Antenatal diagnosis of an intracranial neoplasm is extremely rare.
  • The authors describe a case in which a 21-week-old fetus was found, by using fetal ultrasonography, to have a large intracranial mass.
  • As the tumor increased in size, near-complete brain atrophy ensued.
  • Postmortem analysis confirmed a teratoma occupying a major portion of the intracranial space.
  • The usefulness of fetal MR imaging in monitoring brain development and tumor growth during treatment planning is discussed.
  • [MeSH-major] Brain Neoplasms / embryology. Cerebral Cortex / embryology. Fetal Diseases / physiopathology. Teratoma / embryology
  • [MeSH-minor] Adult. Atrophy. Brain / embryology. Brain / pathology. Female. Fetal Death. Fetal Development. Humans. Labor, Induced. Magnetic Resonance Imaging. Pregnancy. Pregnancy Trimester, First. Pregnancy Trimester, Second. Ultrasonography, Prenatal

  • Genetic Alliance. consumer health - Teratoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16370288.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


83. Nakaya K, Chernov M, Kasuya H, Izawa M, Hayashi M, Kato K, Kubo O, Muragaki Y, Iseki H, Hori T, Okada Y, Takakura K: Risk factors for regrowth of intracranial meningiomas after gamma knife radiosurgery: importance of the histopathological grade and MIB-1 index. Minim Invasive Neurosurg; 2009 Oct;52(5-6):216-21

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Risk factors for regrowth of intracranial meningiomas after gamma knife radiosurgery: importance of the histopathological grade and MIB-1 index.
  • INTRODUCTION: The influence of histopathological grade and MIB-1 index of intracranial meningioma on the results of its radiosurgical management is not clear.
  • PATIENTS AND METHODS: Thirty-four intracranial meningiomas with known detailed histopathological diagnosis were analyzed.
  • In 26 cases the treatment was done at the time of tumor recurrence.
  • Median volume of the neoplasm at the time of GKR was 4.1 mL (range: 0.4-43.1 mL).
  • Histopathological grade II or III (p<0.0001), MIB-1 index 3% and more (p=0.0004), and non-skull base location (p=0.0026) of the tumor showed negative associations with progression-free survival in multivariate analyses.
  • CONCLUSION: Radiosurgery is a highly effective management option for benign intracranial meningiomas, but growth control of non-benign ones is significantly worse.
  • [MeSH-major] Antibodies, Antinuclear / metabolism. Antibodies, Monoclonal / metabolism. Meningeal Neoplasms / surgery. Meningioma / surgery. Neoplasm Recurrence, Local / epidemiology. Neoplasm Recurrence, Local / pathology. Radiosurgery
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / metabolism. Cell Proliferation. Disease Progression. Female. Humans. Male. Middle Aged. Multivariate Analysis. Retrospective Studies. Risk Factors. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20077361.001).
  • [ISSN] 1439-2291
  • [Journal-full-title] Minimally invasive neurosurgery : MIN
  • [ISO-abbreviation] Minim Invasive Neurosurg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antibodies, Antinuclear; 0 / Antibodies, Monoclonal; 0 / Biomarkers, Tumor; 0 / MIB-1 antibody
  •  go-up   go-down


84. Galanov AV, Konovalov AN, Kornienko VN, Il'ialov SR, Kostiuchenko VV, Pronin IN, Mariashev SA, Iakovlev SB, Lubnin AIu, Serova NK, Nikonova NG: [First experience with a Gamma-knife unit used for radiosurgical treatment for intracranial space-occupying lesions]. Zh Vopr Neirokhir Im N N Burdenko; 2007 Jan-Mar;(1):3-10
MedlinePlus Health Information. consumer health - Brain Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [First experience with a Gamma-knife unit used for radiosurgical treatment for intracranial space-occupying lesions].
  • The essence of the radiosurgical treatment is to apply the stereotactic technique to high-precision irradiation of small intracranial targets by narrow beams of ionizing radiation from external sources.
  • Three hundred and six patients with various intracranial diseases (137 with malignant tumors, 136 with benign tumors, and 33 patients with vascular diseases) underwent radiosurgery on a Gamma-Knife unit for over 1.5 years, from May 2005 to October 2006.
  • By summing up the first results, it can be noted that stereotactic radiosurgery using a Gamma-Knife unit is an effective and rather safe technique in the treatment of patients with various types of intracranial pathology, which maintains the high quality of life, reduces the likelihood of development of different neurological disorders after treatment and avoids the risk of operative complications.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Brain Neoplasms / pathology. Brain Neoplasms / radiotherapy. Brain Neoplasms / surgery. Child. Child, Preschool. Equipment Design. Eye Diseases / surgery. Female. Humans. Male. Meningioma / radiotherapy. Meningioma / surgery. Middle Aged. Neoplasm Metastasis. Neuroma, Acoustic / radiotherapy. Neuroma, Acoustic / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17526246.001).
  • [ISSN] 0042-8817
  • [Journal-full-title] Zhurnal voprosy neĭrokhirurgii imeni N. N. Burdenko
  • [ISO-abbreviation] Zh Vopr Neirokhir Im N N Burdenko
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


85. Hoei-Hansen CE, Sehested A, Juhler M, Lau YF, Skakkebaek NE, Laursen H, Rajpert-de Meyts E: New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers. J Pathol; 2006 May;209(1):25-33
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers.
  • Primary intracranial germ cell tumours are rare neoplasms that occur in children and adolescents.
  • Expression at the protein level was analysed in 21 children and young adults with intracranial germinomas and non-germinomas, contributing to a careful description of these unusual tumours and adding to the understanding of pathogenesis.
  • Stem cell related proteins were highly expressed in intracranial germ cell tumours, and many similarities were detected with their gonadal equivalents, including a close similarity with primordial germ cells.
  • [MeSH-major] Brain Neoplasms / pathology. Neoplasms, Germ Cell and Embryonal / pathology. Neoplastic Stem Cells / pathology. Pluripotent Stem Cells / pathology
  • [MeSH-minor] Adolescent. Adult. Antigens, Differentiation / metabolism. Cell Differentiation. Child. Child, Preschool. Embryonal Carcinoma Stem Cells. Female. Gene Expression. Humans. Immunoenzyme Techniques. In Situ Hybridization, Fluorescence. Infant. Infant, Newborn. Male. Neoplasm Proteins / metabolism. Stromal Cells / metabolism. Transcription Factors / metabolism

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
  • (PMID = 16456896.001).
  • [ISSN] 0022-3417
  • [Journal-full-title] The Journal of pathology
  • [ISO-abbreviation] J. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, Differentiation; 0 / Neoplasm Proteins; 0 / Transcription Factors
  •  go-up   go-down


86. Cho J, Choi JU, Kim DS, Suh CO: Low-dose craniospinal irradiation as a definitive treatment for intracranial germinoma. Radiother Oncol; 2009 Apr;91(1):75-9
MedlinePlus Health Information. consumer health - Childhood Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low-dose craniospinal irradiation as a definitive treatment for intracranial germinoma.
  • PURPOSE: To determine the optimal radiotherapy (RT) dose and volume for treatment of intracranial germinoma.
  • MATERIALS AND METHODS: Eighty-one intracranial germinoma patients (33 pathologically-verified; 48 presumed by radiosensitivity testing) treated with RT alone between 1971 and 2002 were analyzed.
  • CONCLUSION: Low-dose CSI-based RT should remain the standard treatment for intracranial germinoma.
  • The RT dose can be reduced to 39.3 Gy for primary tumor sites and to 19.5 Gy for the spinal axis.
  • [MeSH-major] Brain Neoplasms / radiotherapy. Cranial Irradiation / methods. Germinoma / radiotherapy
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Female. Follow-Up Studies. Humans. Male. Neoplasm Recurrence, Local. Quality of Life. Radiotherapy Dosage. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Germinoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19019472.001).
  • [ISSN] 0167-8140
  • [Journal-full-title] Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • [ISO-abbreviation] Radiother Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


87. Mirzayan MJ, Gharabaghi A, Samii M, Tatagiba M, Krauss JK, Rosahl SK: Response of C-reactive protein after craniotomy for microsurgery of intracranial tumors. Neurosurgery; 2007 Apr;60(4):621-5; discussion 625
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Response of C-reactive protein after craniotomy for microsurgery of intracranial tumors.
  • METHODS: CRP was measured for 10 days in 46 patients who underwent elective craniotomy for microsurgery of intracranial tumors.
  • CONCLUSION: Because CRP can be considerably increased in patients for 4 days after regular intracranial surgery, its diagnostic value during this period is limited.
  • [MeSH-major] Biomarkers, Tumor / blood. Brain Neoplasms / blood. Brain Neoplasms / surgery. C-Reactive Protein / analysis. Craniotomy. Microsurgery. Neoplasm Proteins / blood. Neurosurgical Procedures
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Humans. Male. Middle Aged. Reproducibility of Results. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17415198.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins; 9007-41-4 / C-Reactive Protein
  •  go-up   go-down


88. Karaman E, Saritzali G, Cansiz H: A case of increased intracranial pressure after unilateral modified radical neck dissection. Am J Otolaryngol; 2009 Jul-Aug;30(4):261-3
Hazardous Substances Data Bank. ACETAZOLAMIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of increased intracranial pressure after unilateral modified radical neck dissection.
  • OBJECTIVE: This study aimed to study case reports and review the world literature concerning increased intracranial pressure secondary to unilateral radical neck dissection.
  • CONCLUSION: Based on our case, vascular anomalies should be considered in any patient who exhibits signs of increased intracranial pressure after unilateral neck dissection.
  • [MeSH-major] Carcinoma, Papillary / secondary. Intracranial Hypertension / etiology. Intracranial Pressure / physiology. Neck Dissection / adverse effects. Thyroid Neoplasms / pathology
  • [MeSH-minor] Acetazolamide / therapeutic use. Biopsy, Needle. Diagnosis, Differential. Diuretics / therapeutic use. Follow-Up Studies. Humans. Magnetic Resonance Angiography. Male. Neoplasm Metastasis. Thyroidectomy. Tomography, X-Ray Computed. Young Adult

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19563938.001).
  • [ISSN] 1532-818X
  • [Journal-full-title] American journal of otolaryngology
  • [ISO-abbreviation] Am J Otolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Diuretics; O3FX965V0I / Acetazolamide
  •  go-up   go-down


89. Santos-Franco JA, Barragán A, Mercado-Pimentel R, Ortiz-Velásquez I, García-Pastor C, Barquet-Platón EI, Pane-Pianesse C, Gómez-Llata S: [Intracranial trigeminal schwannoma with extension to infratemporal fossa, parapharyngeal space, orbit, maxillary sinus and nasal fossa]. Neurocirugia (Astur); 2005 Feb;16(1):67-74
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intracranial trigeminal schwannoma with extension to infratemporal fossa, parapharyngeal space, orbit, maxillary sinus and nasal fossa].
  • Schwannomas reach 8 to 10% of all intracranial tumors.
  • [MeSH-major] Cranial Nerve Neoplasms / pathology. Maxillary Sinus / pathology. Neurilemmoma / pathology. Trigeminal Nerve / pathology
  • [MeSH-minor] Adult. Brain / pathology. Brain / surgery. Female. Humans. Nasal Cavity / pathology. Nasal Cavity / surgery. Neoplasm Invasiveness. Orbit / pathology. Orbit / surgery. Pharynx / pathology. Pharynx / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15756415.001).
  • [ISSN] 1130-1473
  • [Journal-full-title] Neurocirugía (Asturias, Spain)
  • [ISO-abbreviation] Neurocirugia (Astur)
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


90. Inoue T, Nishimura S, Hayashi N, Numagami Y, Midorikawa H, Shimamura N, Yajima N, Nishijima M: [Intracranial osteolytic hemangiopericytoma manifesting as a rapidly enlarging extracranial soft tissue mass lesion]. No Shinkei Geka; 2007 Mar;35(3):275-80
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intracranial osteolytic hemangiopericytoma manifesting as a rapidly enlarging extracranial soft tissue mass lesion].
  • Hemangiopericytoma is a highly vascular and rapidly growing tumor, which tends to recur at distant locations.
  • A 31-year-old male presented with intracranial osteolytic hemangiopericytoma manifesting as a rapidly enlarging extracranial soft tissue mass lesion causing a subcutaneous mass in the forehead.
  • Angiography demonstrated obstruction of the superior sagittal sinus and dense tumor staining with slow circulation and venous drainage.
  • [MeSH-major] Hemangiopericytoma / surgery. Skin Neoplasms / pathology. Skull Neoplasms / surgery
  • [MeSH-minor] Adult. Diagnosis, Differential. Frontal Lobe / pathology. Humans. Magnetic Resonance Imaging. Male. Neoplasm Invasiveness. Soft Tissue Neoplasms / pathology. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Hemangiopericytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] No Shinkei Geka. 2007 Apr;35(4):412
  • (PMID = 17352153.001).
  • [ISSN] 0301-2603
  • [Journal-full-title] No shinkei geka. Neurological surgery
  • [ISO-abbreviation] No Shinkei Geka
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


91. Ziadi A, Saliba I: Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review. Auris Nasus Larynx; 2010 Oct;37(5):539-45
Genetic Alliance. consumer health - Malignant peripheral nerve sheath tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
  • OBJECTIVES: The incidence of malignant peripheral nerve sheath tumor (MPNST) is approximately 0.001%.
  • Those involving intracranial nerves are even more exceptional.
  • (1) to review all cases of intracranial MPNST described in the literature, (2) to highlight the suspicion of intracranial MPNST, (3) to identify the gross pathology, the histopathology, the immunohistochemistry, (4) to discuss the differential diagnosis, the treatment, the recurrence rate, the follow-up, the incidence of metastasis and the prognosis.
  • We used the following Keywords: "malignant peripheral nerve sheath tumor", "cranial nerve", "neurosarcoma", "malignant schwannoma", "neurofibroma", "malignant neurofibroma" and "nerve tumor".
  • We considered cases where MPNST involved an intracranial cranial nerve.
  • 13 cases were treated with radiotherapy for tumor recurrence and metastasis.
  • [MeSH-major] Cranial Nerve Neoplasms / diagnosis. Nerve Sheath Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Cell Transformation, Neoplastic / pathology. Child. Child, Preschool. Diagnosis, Differential. Disease-Free Survival. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / mortality. Neoplasm Recurrence, Local / pathology. Neurilemmoma / diagnosis. Neurilemmoma / pathology. Neurilemmoma / radiotherapy. Neurilemmoma / surgery. Neurofibroma / diagnosis. Neurofibroma / pathology. Neurofibroma / radiotherapy. Neurofibroma / surgery. Neurofibromatosis 1 / diagnosis. Neurofibromatosis 1 / pathology. Neurofibromatosis 1 / radiotherapy. Neurofibromatosis 1 / surgery. Neurofibromatosis 2 / diagnosis. Neurofibromatosis 2 / pathology. Neurofibromatosis 2 / radiotherapy. Neurofibromatosis 2 / surgery. Radiotherapy, Adjuvant. Spinal Neoplasms / mortality. Spinal Neoplasms / pathology. Spinal Neoplasms / secondary. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 20399579.001).
  • [ISSN] 1879-1476
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 35
  •  go-up   go-down


92. Preusser M, Wolfsberger S, Czech T, Slavc I, Budka H, Hainfellner JA: Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome. Am J Clin Pathol; 2005 Oct;124(4):543-9
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome.
  • Survivin expression has been described as prognostic factor in various tumor types and has been shown to correlate with cytologic anaplasia in ependymoma.
  • We immunohistochemically studied survivin expression and its association with Ki-67 and topoisomerase IIalpha (TIIalpha) expression and outcome in 63 patients with intracranial ependymoma.
  • Survivin is expressed in a fraction of nuclei of tumor and endothelial cells including mitotic figures.
  • On average, 62.86% of Ki-67-expressing tumor cell nuclei coexpress survivin, whereas 92.2% of survivin-expressing nuclei coexpress Ki-67.
  • [MeSH-major] Brain Neoplasms / metabolism. Cell Proliferation. Cysteine Proteinase Inhibitors / metabolism. Ependymoma / metabolism. Microtubule-Associated Proteins / metabolism. Neoplasm Proteins / metabolism
  • [MeSH-minor] Adolescent. Adult. Aged. Antigens, Neoplasm / metabolism. Austria / epidemiology. Biomarkers, Tumor. Cell Nucleus / metabolism. Cell Nucleus / pathology. Child. Child, Preschool. Cohort Studies. DNA Topoisomerases, Type II / metabolism. DNA-Binding Proteins / metabolism. Humans. Infant. Inhibitor of Apoptosis Proteins. Ki-67 Antigen / metabolism. Middle Aged. Neoplasm Staging. Prognosis. Survival Rate

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16146813.001).
  • [ISSN] 0002-9173
  • [Journal-full-title] American journal of clinical pathology
  • [ISO-abbreviation] Am. J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / BIRC5 protein, human; 0 / Biomarkers, Tumor; 0 / Cysteine Proteinase Inhibitors; 0 / DNA-Binding Proteins; 0 / Inhibitor of Apoptosis Proteins; 0 / Ki-67 Antigen; 0 / Microtubule-Associated Proteins; 0 / Neoplasm Proteins; EC 5.99.1.3 / DNA Topoisomerases, Type II; EC 5.99.1.3 / DNA topoisomerase II alpha
  •  go-up   go-down


93. Ozişik PA, Işikay I, Oruçkaptan H, Söylemezoğlu F, Ozcan OE: Unusual massive spinal metastasis of an intracranial oligodendroglioma. Turk Neurosurg; 2008 Jul;18(3):276-80
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unusual massive spinal metastasis of an intracranial oligodendroglioma.
  • Herein, we present a case of anaplastic oligodendroglioma with massive spinal metastasis in the first post-operative year without any residual tumor or recurrence in the primary tumor site.
  • [MeSH-major] Brain Neoplasms / pathology. Neoplasm Seeding. Oligodendroglioma / secondary. Spinal Neoplasms / secondary
  • [MeSH-minor] Adult. Fatal Outcome. Humans. Magnetic Resonance Imaging. Male. Postoperative Complications

  • Genetic Alliance. consumer health - Oligodendroglioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18814118.001).
  • [ISSN] 1019-5149
  • [Journal-full-title] Turkish neurosurgery
  • [ISO-abbreviation] Turk Neurosurg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


94. Eom KY, Kim IH, Park CI, Kim HJ, Kim JH, Kim K, Kim SK, Wang KC, Cho BG, Jung HW, Heo DS, Kang HJ, Shin HY, Ahn HS: Upfront chemotherapy and involved-field radiotherapy results in more relapses than extended radiotherapy for intracranial germinomas: modification in radiotherapy volume might be needed. Int J Radiat Oncol Biol Phys; 2008 Jul 1;71(3):667-71
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Upfront chemotherapy and involved-field radiotherapy results in more relapses than extended radiotherapy for intracranial germinomas: modification in radiotherapy volume might be needed.
  • PURPOSE: To retrospectively compare the outcome of upfront chemotherapy plus radiotherapy (CRT) and the outcome of the use of extended radiotherapy (RT) only for intracranial germinoma.
  • METHODS AND MATERIALS: Of 81 patients with tissue-confirmed intracranial germinoma, 42 underwent CRT and 39 underwent RT only.
  • [MeSH-major] Brain Neoplasms / mortality. Brain Neoplasms / therapy. Drug Therapy / mortality. Germinoma / mortality. Germinoma / therapy. Neoplasm Recurrence, Local / mortality. Neoplasm Recurrence, Local / prevention & control. Radiotherapy, Adjuvant / mortality
  • [MeSH-minor] Adolescent. Adult. Child. Female. Humans. Korea / epidemiology. Male. Radiotherapy. Retrospective Studies. Risk Assessment / methods. Risk Factors. Survival Analysis. Survival Rate. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • MedlinePlus Health Information. consumer health - Medicines and Children.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18514777.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


95. Cornelius JF, George B, Kolb F: Combined use of a radial fore arm free flap for extra-intracranial bypass and for antero-lateral skull base reconstruction--a new technique and review of literature. Acta Neurochir (Wien); 2006 Apr;148(4):427-34
MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined use of a radial fore arm free flap for extra-intracranial bypass and for antero-lateral skull base reconstruction--a new technique and review of literature.
  • This article describes a new surgical technique consisting of the combined use of a fascial radial fore arm free flap (RFFF) as vascular graft for extra-intracranial bypass and as dura mater plasty for reconstruction of the antero-lateral skull base.
  • This new technique is illustrated by a case of a complex intracranial meningioma with extracranial extension necessitating resection of internal carotid artery.
  • The technical issues of antero-lateral skull base reconstruction and extra-intracranial bypass are discussed and the literature is reviewed.
  • [MeSH-major] Cerebral Revascularization / methods. Meningeal Neoplasms / surgery. Meningioma / surgery. Neurosurgical Procedures / methods. Reconstructive Surgical Procedures / methods. Skull Base Neoplasms / surgery. Surgical Flaps
  • [MeSH-minor] Adult. Carotid Artery, Internal / pathology. Carotid Artery, Internal / surgery. Dura Mater / surgery. Fascia / anatomy & histology. Fascia / surgery. Fascia / transplantation. Forearm / anatomy & histology. Forearm / surgery. Humans. Male. Middle Cerebral Artery / pathology. Middle Cerebral Artery / surgery. Neoplasm Recurrence, Local. Neoplasm, Residual / pathology. Neoplasm, Residual / surgery. Neoplasms, Radiation-Induced / pathology. Neoplasms, Radiation-Induced / surgery. Orbital Neoplasms / pathology. Orbital Neoplasms / surgery. Paranasal Sinus Neoplasms / pathology. Paranasal Sinus Neoplasms / surgery. Radiotherapy / adverse effects. Skull Base / pathology. Skull Base / radiography. Skull Base / surgery. Temporal Arteries / pathology. Temporal Arteries / surgery. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16475019.001).
  • [ISSN] 0001-6268
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Austria
  •  go-up   go-down


96. Matsunaga S, Shuto T, Inomori S, Fujino H, Yamamoto I: Gamma knife radiosurgery for intracranial haemangioblastomas. Acta Neurochir (Wien); 2007 Oct;149(10):1007-13; discussion 1013
MedlinePlus Health Information. consumer health - Von Hippel-Lindau Disease.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gamma knife radiosurgery for intracranial haemangioblastomas.
  • [MeSH-major] Brain Neoplasms / surgery. Hemangioblastoma / surgery. Radiosurgery. von Hippel-Lindau Disease / surgery
  • [MeSH-minor] Adult. Aged. Brain / pathology. Brain / surgery. Cysts / diagnosis. Cysts / pathology. Cysts / surgery. Female. Follow-Up Studies. Humans. Kaplan-Meier Estimate. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / surgery. Prognosis. Reoperation. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17712513.001).
  • [ISSN] 0942-0940
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Austria
  •  go-up   go-down


97. Lee JW, Kang KW, Park SH, Lee SM, Paeng JC, Chung JK, Lee MC, Lee DS: 18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma. Eur J Nucl Med Mol Imaging; 2009 Oct;36(10):1574-82
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] 18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma.
  • METHODS: Fifty-nine patients (27 men and 32 women) with intracranial meningioma who underwent preoperative FDG PET and subsequent surgical resection were enrolled.
  • All patients underwent clinical follow-up for tumor recurrence with a mean duration of 34+/-20 months.
  • The tumor to gray matter ratio (TGR) of FDG uptake was calculated and a receiver-operating characteristic (ROC) curve of the TGR was drawn to determine the cutoff value of the TGR for detection of high-grade meningioma.
  • RESULTS: The TGR in high-grade meningioma (WHO grade II and III) was significantly higher than that in low-grade ones (WHO grade I) (p=0.002) and significantly correlated with the MIB-1 labeling index (r=0.338, p=0.009) and mitotic count of the tumor (r=0.284, p=0.03).
  • In the log-rank test, the TGR, MIB-1 labeling index, presence of brain invasion, and WHO grade were significantly associated with tumor recurrence.
  • The cumulative recurrence-free survival rate of patients with a TGR of 1.0 or less was significantly higher than that of patients with a TGR of more than 1.0 (p=0.0003) CONCLUSION: FDG uptake in meningioma was the significant predictive factor of tumor recurrence and significantly correlated with the proliferative potential of the tumor.
  • [MeSH-major] Brain Neoplasms / radionuclide imaging. Fluorodeoxyglucose F18. Meningioma / radionuclide imaging. Radiopharmaceuticals
  • [MeSH-minor] Adult. Aged. Disease-Free Survival. Female. Fluorine Radioisotopes. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Recurrence, Local / radionuclide imaging. Positron-Emission Tomography. ROC Curve

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19377904.001).
  • [ISSN] 1619-7089
  • [Journal-full-title] European journal of nuclear medicine and molecular imaging
  • [ISO-abbreviation] Eur. J. Nucl. Med. Mol. Imaging
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Fluorine Radioisotopes; 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


98. Giesel FL, Mehndiratta A, Risse F, Rius M, Zechmann CM, von Tengg-Kobligk H, Gerigk L, Kauczor HU, Politi M, Essig M, Griffiths PD, Wilkinson ID: Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla. Acta Radiol; 2009 Jun;50(5):521-30
Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla.
  • PURPOSE: To investigate possible intraindividual differences of high- versus low-molar contrast agents on PWI at 3T in patients with intracranial space-occupying lesions.
  • On each occasion, an exogenous contrast-based, T2*-weighted, gradient-recalled echo-planar imaging (EPI) technique was used to determine the intracranial perfusion characteristics using one of two intravenous contrast agents: either 5 ml of 1.0 M gadobutrol or 10 ml of 0.5 M gadopentetate dimeglumine.
  • The ratio of C(max) between the whole tumor and whole normal side hemisphere was higher in five out of the six intraaxial tumor cases.
  • A significantly higher ratio (Delta C(max)/C(max)) in the difference between C(max) of gray and white matter (from hemisphere without brain lesion) compared to C(max) for the hemisphere containing the neoplasm (hemisphere with brain lesion) was demonstrated for gadobutrol in intraaxial tumors (P<0.05).
  • CONCLUSION: Higher-concentration 1.0 M gadobutrol can offer advantages over standard 0.5 M gadopentetate dimeglumine, particularly with respect to delineation between gray and white matter and for the demarcation of highly vascularized tumor tissue on brain PWI performed at 3T.
  • [MeSH-major] Brain Neoplasms / diagnosis. Gadolinium DTPA. Image Enhancement / methods. Lymphoma, Non-Hodgkin / diagnosis. Magnetic Resonance Imaging / methods. Neoplasms, Nerve Tissue / diagnosis. Organometallic Compounds
  • [MeSH-minor] Adult. Aged. Brain / blood supply. Brain / pathology. Brain Mapping / methods. Cerebrovascular Circulation. Contrast Media. Humans. Image Processing, Computer-Assisted / methods. Middle Aged

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19337867.001).
  • [ISSN] 1600-0455
  • [Journal-full-title] Acta radiologica (Stockholm, Sweden : 1987)
  • [ISO-abbreviation] Acta Radiol
  • [Language] eng
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article
  • [Publication-country] Sweden
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Organometallic Compounds; 1BJ477IO2L / gadobutrol; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


99. Tang L, Cianfoni A, Imbesi SG: Diffusion-weighted imaging distinguishes recurrent epidermoid neoplasm from postoperative arachnoid cyst in the lumbosacral spine. J Comput Assist Tomogr; 2006 May-Jun;30(3):507-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diffusion-weighted imaging distinguishes recurrent epidermoid neoplasm from postoperative arachnoid cyst in the lumbosacral spine.
  • Diffusion-weighted imaging can be used to distinguish epidermoid tumor from arachnoid cyst in the intracranial compartment.
  • We report the use of diffusion-weighted imaging in a postoperative spine to successfully distinguish a recurrent epidermoid tumor from arachnoid cyst in a noninvasive manner.
  • [MeSH-major] Arachnoid Cysts / diagnosis. Carcinoma, Squamous Cell / diagnosis. Diffusion Magnetic Resonance Imaging. Spinal Neoplasms / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Lumbosacral Region. Neoplasm Recurrence, Local. Postoperative Complications / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16778630.001).
  • [ISSN] 0363-8715
  • [Journal-full-title] Journal of computer assisted tomography
  • [ISO-abbreviation] J Comput Assist Tomogr
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


100. Saito K, Katsumata Y, Hirabuki T, Kato K, Yamanaka M: Fetus-in-fetu: parasite or neoplasm? A study of two cases. Fetal Diagn Ther; 2007;22(5):383-8
MedlinePlus Health Information. consumer health - Fetal Health and Development.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fetus-in-fetu: parasite or neoplasm? A study of two cases.
  • CASE 1: A fetal retroperitoneal cystic tumor including two masses was detected by ultrasonography at 26 gestational weeks.
  • CASE 2: An intracranial tumor with hydrocephalus was detected by ultrasonography at 19 gestational weeks.
  • [MeSH-major] Fetal Diseases / parasitology. Fetal Diseases / ultrasonography. Neoplasms / ultrasonography
  • [MeSH-minor] Adult. Animals. Female. Fetus. Humans. Parasites. Pregnancy. Teratoma / ultrasonography. Twins

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2007 S. Karger AG, Basel.
  • (PMID = 17556829.001).
  • [ISSN] 1421-9964
  • [Journal-full-title] Fetal diagnosis and therapy
  • [ISO-abbreviation] Fetal. Diagn. Ther.
  • [Language] eng
  • [Publication-type] Case Reports; Comparative Study; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down






Advertisement